JPS6320432B2 - - Google Patents
Info
- Publication number
- JPS6320432B2 JPS6320432B2 JP58061497A JP6149783A JPS6320432B2 JP S6320432 B2 JPS6320432 B2 JP S6320432B2 JP 58061497 A JP58061497 A JP 58061497A JP 6149783 A JP6149783 A JP 6149783A JP S6320432 B2 JPS6320432 B2 JP S6320432B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- het
- compounds
- imidazolyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 42
- -1 2-imidazolyl group Chemical group 0.000 claims description 27
- 150000003839 salts Chemical class 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 6
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims description 5
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 claims description 5
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 3
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 3
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 3
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims description 3
- 125000005493 quinolyl group Chemical group 0.000 claims description 3
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 125000004149 thio group Chemical group *S* 0.000 claims 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 27
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 239000000243 solution Substances 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 150000003462 sulfoxides Chemical class 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical group OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 7
- 206010017533 Fungal infection Diseases 0.000 description 7
- 208000031888 Mycoses Diseases 0.000 description 7
- 238000000921 elemental analysis Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000000843 anti-fungal effect Effects 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 239000012312 sodium hydride Substances 0.000 description 5
- 229910000104 sodium hydride Inorganic materials 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 241000222122 Candida albicans Species 0.000 description 4
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 229940121375 antifungal agent Drugs 0.000 description 4
- 229940095731 candida albicans Drugs 0.000 description 4
- 229960002798 cetrimide Drugs 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 150000003457 sulfones Chemical class 0.000 description 4
- BPLKQGGAXWRFOE-UHFFFAOYSA-M trimethylsulfoxonium iodide Chemical compound [I-].C[S+](C)(C)=O BPLKQGGAXWRFOE-UHFFFAOYSA-M 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 125000000623 heterocyclic group Chemical group 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 241001225321 Aspergillus fumigatus Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 201000007336 Cryptococcosis Diseases 0.000 description 2
- 241000221204 Cryptococcus neoformans Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241001480037 Microsporum Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- 229940091771 aspergillus fumigatus Drugs 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- YKGMKSIHIVVYKY-UHFFFAOYSA-N dabrafenib mesylate Chemical compound CS(O)(=O)=O.S1C(C(C)(C)C)=NC(C=2C(=C(NS(=O)(=O)C=3C(=CC=CC=3F)F)C=CC=2)F)=C1C1=CC=NC(N)=N1 YKGMKSIHIVVYKY-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- XOHMICFWUQPTNP-UHFFFAOYSA-N 1-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl)ethanone Chemical compound ClC1=CC(Cl)=CC=C1C(=O)CN1N=CN=C1 XOHMICFWUQPTNP-UHFFFAOYSA-N 0.000 description 1
- AFBBKYQYNPNMAT-UHFFFAOYSA-N 1h-1,2,4-triazol-1-ium-3-thiolate Chemical compound SC=1N=CNN=1 AFBBKYQYNPNMAT-UHFFFAOYSA-N 0.000 description 1
- SNTWKPAKVQFCCF-UHFFFAOYSA-N 2,3-dihydro-1h-triazole Chemical compound N1NC=CN1 SNTWKPAKVQFCCF-UHFFFAOYSA-N 0.000 description 1
- DAQFFBNMQPACAK-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)-1-(1,3-thiazol-2-ylsulfanyl)-3-(1,2,4-triazol-1-yl)propan-2-ol Chemical compound C1=NC=NN1CC(C=1C(=CC(Cl)=CC=1)Cl)(O)CSC1=NC=CS1 DAQFFBNMQPACAK-UHFFFAOYSA-N 0.000 description 1
- FUBHOAZDIOJQQC-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)-1-(1-methylimidazol-2-yl)sulfinyl-3-(1,2,4-triazol-1-yl)propan-2-ol Chemical compound CN1C=CN=C1S(=O)CC(O)(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 FUBHOAZDIOJQQC-UHFFFAOYSA-N 0.000 description 1
- NSQKIIHIIMUTDS-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)-1-[(4,5-dimethyl-1,3-thiazol-2-yl)sulfinyl]-3-(1,2,4-triazol-1-yl)propan-2-ol Chemical compound S1C(C)=C(C)N=C1S(=O)CC(O)(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 NSQKIIHIIMUTDS-UHFFFAOYSA-N 0.000 description 1
- DASJDMQCPIDJIF-UHFFFAOYSA-N 2-bromo-1-(2,4-dichlorophenyl)ethanone Chemical compound ClC1=CC=C(C(=O)CBr)C(Cl)=C1 DASJDMQCPIDJIF-UHFFFAOYSA-N 0.000 description 1
- OCVLSHAVSIYKLI-UHFFFAOYSA-N 3h-1,3-thiazole-2-thione Chemical compound SC1=NC=CS1 OCVLSHAVSIYKLI-UHFFFAOYSA-N 0.000 description 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 1
- ZFWJVKLPEZPKNL-UHFFFAOYSA-N 5-propyl-1h-1,2,4-triazole Chemical compound CCCC1=NC=NN1 ZFWJVKLPEZPKNL-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000335423 Blastomyces Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000223203 Coccidioides Species 0.000 description 1
- 241000223205 Coccidioides immitis Species 0.000 description 1
- 241001480079 Corymbia calophylla Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- 241001480036 Epidermophyton floccosum Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000228402 Histoplasma Species 0.000 description 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 206010065764 Mucosal infection Diseases 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 241001537205 Paracoccidioides Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 1
- 241000222126 [Candida] glabrata Species 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- DKWOHBPRFZIUQL-UHFFFAOYSA-N dimethyl-methylidene-oxo-$l^{6}-sulfane Chemical compound C[S+](C)([CH2-])=O DKWOHBPRFZIUQL-UHFFFAOYSA-N 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- INOVPRROYBTWMK-UHFFFAOYSA-N methanesulfonic acid oxirane Chemical compound C1CO1.CS(=O)(=O)O INOVPRROYBTWMK-UHFFFAOYSA-N 0.000 description 1
- PMRYVIKBURPHAH-UHFFFAOYSA-N methimazole Chemical compound CN1C=CNC1=S PMRYVIKBURPHAH-UHFFFAOYSA-N 0.000 description 1
- YNJTXFXKTZJFPP-UHFFFAOYSA-N n-[5-[2-(2,4-dichlorophenyl)-2-hydroxy-3-(1,2,4-triazol-1-yl)propyl]sulfanyl-1,3,4-thiadiazol-2-yl]acetamide Chemical compound S1C(NC(=O)C)=NN=C1SCC(O)(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 YNJTXFXKTZJFPP-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000002511 suppository base Substances 0.000 description 1
- 229940042055 systemic antimycotics triazole derivative Drugs 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229940045860 white wax Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
æ¬çºæã¯ãæçè掻æ§ããã¡ããããå«ãåç©
ã«ãããŠçèææã®æ²»çã«æçšã§ããæ°èŠãªããª
ã¢ãŸãŒã«èªå°äœã«é¢ããã æ¬çºæã«ããã°ãæ¬¡åŒ ïŒåŒäžArã¯ïŒïŒïŒâãžããããšãã«åºã§ããã ïœã¯ïŒãŸãã¯ïŒã§ããã Hetã¯ïŒâã€ãããŸãªã«åºãïŒâãã¢ãŸãªã«
åºãïŒâïŒïŒïŒïŒïŒïŒâããªã¢ãŸãªã«ïŒåºãïŒâ
ããã©ãŸãªã«åºãïŒâïŒïŒïŒïŒïŒïŒâãã¢ãžã¢ãŸ
ãªã«åºïŒãïŒâãïŒâãããã¯ïŒâããªãžã«åºã
ïŒâãããã¯ïŒâããªããžãã«åºããããªã«åºã
ãã³ãŸãã¢ãŸãªã«åºãŸãã¯ããªãã«åºã§ãããã
ãããè€çŽ ç°ãŸãã¯çž®åããšãã«ç°ã«ãããŠïŒå
ãŸãã¯ãã以äžã®ããã²ã³ãCF3ãC1âC4ã¢ã«ã
ã«åºãC1âC4ã¢ã«ã³ãã·åºãã¢ããåºãã¢ãã
ããã¯ãžC1âC4ã¢ã«ãã«âã¢ããåºãã¢ã«ã«ã
ã€ã«ã¢ããåºãæ°Žé žåºãŸãã¯ããªåºã«ãã眮æã
ããŠããŠãããïŒ ã®ååç©ããã³è¬å€åŠçã«å容ã§ãããããã®å¡©
ãæäŸãããã Arã¯å¥œãŸããã¯ïŒïŒïŒâãžã¯ãã«ããšãã«åº
ã§ããã 奜ãŸããè€çŽ ç°æ®åºã«ã¯ã€ãããŸãªã«åºãããª
ããžãã«åºããã³ãã¢ãŸãªã«åºãç¹ã«ïŒâã€ãã
ãŸãªã«åºãïŒâïŒïŒâã¡ãã«âã€ãããŸãªã«åºïŒã
ïŒâãã¢ãŸãªã«åºããªãã³ã«ïŒâããã³ïŒâããª
ããžãã«åºãå«ãŸããã ã¢ã«ãã«åºãã¢ã«ã³ãã·åºããã³ã¢ã«ã«ãã€ã«
åºã¯é©å®çŽéã§ãã€ãŠãåæéã§ãã€ãŠãããã æ¬çºæã¯ãåŒïŒïŒã®ååç©ãããã¯è¬åŠçã«
å容ã§ãããããã®å¡©ãããã³è¬åŠçã«å容ã§ã
ãåžéå€ãããã¯ãã€ãªã€ãŒãå«ãè¬å€çµæç©ã
æäŸããã ããã«æ¬çºæã¯ããããå«ãåç©ã«ãããŠçè
ææã®æ²»çã«äœ¿çšããããã®åŒïŒïŒã®ååç©ãŸ
ãã¯è¬åŠçã«å容ã§ãããããã®å¡©ãæäŸããã åŒïŒïŒã®ååç©ã¯æ¬çºæã«åŸã€ãŠå€çš®ã®æ¹æ³
ã«ããåŸãããšãã§ããã ïŒ äžæ¹æ³ã«ãããŠã¯ãïœãïŒã§ããåŒïŒïŒã®
ååç©ãæ¬¡åŒ ã®ãªãã·ã©ã³ããæ¬¡åŒ HetâSH ⊠ã®è€çŽ ç°åŒããªãŒã«ïŒãããã®åŒäžArããã³
Hetã¯å ãã«å®çŸ©ããããã®ã§ããïŒãšã®åå¿
ã«ãã€ãŠè£œé ããããšãã§ããã ãã®åå¿ã¯ãããçšåºŠã¯åå¿é¢äžäœã®å³å¯ãª
æ§è³ªã«å¿ããŠå€æ§ãªæ¡ä»¶äžã§éæããããäžè¬
ã«åžžæ³ã«ãããªãã·ã©ã³ïŒïŒããã®éé¢å¡©åº
ãšããŠãææ©æº¶å€ããšãã°ãžãªããµã³äžã§éå°
ã®è€çŽ ç°åŒããªãŒã«ïŒïŒãšå ±ã«å ç±ããããš
ã«ãã€ãŠåå¿ãè¡ãããšãã§ãããéæµæž©åºŠã§
ïŒæ¥ãŸã§ã®æéã§äžè¬ã«ååã§ãããã觊åªé
ã®åžæ°Žé žåãããªãŠã 溶液ã®æ·»å ã«ãã€ãŠãã°
ãã°åçãæ¹åãããåå¿æéãççž®ãããã
çæç©ã¯åžžæ³ã«ãããããšãã°æº¶å€ãèžçºã
ããçæç©ãæ°Žãšæ··åãããææ©æº¶å€ã«å ¥ãã
çæç©ãäœæ¿åºŠã®æ°Žé žåãããªãŠã ãŸãã¯çé ž
ã«ãªãŠã ã®æº¶æ¶²ã§æœåºããæªåå¿ããªãŒã«ãé€
å»ãã也æããã溶å€ãèžçºãããããšã«ãã€
ãŠåé¢ã粟補ããããšãã§ãããçæç©ã¯ææ
ã«ããçµæ¶åãŸãã¯ã¯ãããã°ã©ãã€ãŒã«ãã€
ãŠããã«ç²Ÿè£œããããšãã§ããã 代æ¿æ³ãšããŠã¯ããªãã·ã©ã³ïŒãã®ã¡ã¿ã³ã¹
ã«ãã³é žå¡©ãšããŠïŒããã³è€çŽ ç°åŒããªãŒã«ã
å ±ã«ææ©æº¶åªïŒããšãã°ïŒ®ïŒïŒ®âãžã¡ãã«ãã«
ã ã¢ãããŸãã¯ããã©ããããã©ã³ïŒäžã§å¡©åº
ããšãã°çé žã«ãªãŠã ãŸãã¯æ°ŽçŽ åãããªãŠã
ã®ååšäžã«å ç±ããã60ã80âã®æž©åºŠãäžè¬ã«
çšãããããããã®æ¡ä»¶äžã§åå¿ã¯äžè¬ã«æ°æ
é以å ã«å®è³ªçã«çµäºãããçæç©ã¯åèšã®ã
ãã«åé¢ã粟補ãããã ä»ã®å€æ³ãšããŠããªãã·ã©ã³ããã®ã¡ã¿ã³ã¹
ã«ãã³é žå¡©ãšããŠéå°ã®è€çŽ ç°åŒããªãŒã«ãšå ±
ã«éæµäžã«æ°·é ¢é žäžã§æ°æéå ç±ããã ãªãã·ã©ã³ïŒïŒã¯åžžæ³ã«ãããäžè¬ã«å¯Ÿå¿
ããã±ãã³ïŒïŒ ãããžã¡ãã«ãªããœã¹ã«ãããŠã ã¡ããªãŒã
ïŒãšãŠåããªã¡ãã«ã¹ã«ãããœããŠã ãããžã¡
ãã«ã¹ã«ããã·ãäžã®æ°ŽçŽ åãããªãŠã ããã
ã¯æ°Žããã³ãã«ãšã³ã®æ··åç©äžã®ã»ããªãã
ïŒcetrimideïŒããã³æ°Žé žåãããªãŠã ãçšããŠ
補é ããããã®ïŒãšã®åå¿ã«ããåŸãããšãã§
ããã æ°ŽçŽ åãããªãŠã ãçšããåå¿ã¯äžè¬ã«ä¹Ÿç¥
ç²æ«ç¶ã®ãšãŠåããªã¡ãã«ã¹ã«ãããœããŠã ã
ãžã¡ãã«ã¹ã«ããã·ãäžã®æ°ŽçŽ åãããªãŠã æž
æ¿æ¶²ã«æ·»å ããããšã«ãã€ãŠéæãããã宀枩
ã§ããšãã°30åéæªæããã®ã¡ãã±ãã³ïŒïŒ
ããžã¡ãã«ã¹ã«ããã·ãäžã§ã»ãŒåœã¢ã«éæ·»å
ãããåå¿æ··åç©ãå æž©ããŠåå¿ãä¿é²ããã
ããšãã§ãã50ã80âã§æ°æéåŸã«åžžæ³ã«ãã
çæç©ãåé¢ããããšãã§ããã ã»ããªãããçšããåå¿ã¯äžè¬ã«ã±ãã³
ïŒïŒããšãŠåããªã¡ãã«ã¹ã«ãããœããŠã ãã
ã³ã»ããªããããã«ãšã³ããã³æ°Žé žåãããªãŠ
ã ã®æ··åç©äžã§çŽïŒæéãçŽ100â以äžã§äºã
ã«æ¿ããæªæããããšã«ãã€ãŠéæãããã次
ãã§åžžæ³ã«ããçæç©ãªãã·ã©ã³ãåé¢ããã
ãšãã§ããã Arããªã«ã眮æåºãå«ãŸãªãããšãã«åºã§
ããããŸãã¯ãããšããªã«åºã§ããå Žåãã»ã
ãªããçµè·¯ãæ¡çšãã¹ãã§ããã ã±ãã³ïŒïŒã¯æ¢ç¥ã®ååç©ã§ãããããŸã
ã¯å è¡æè¡ã«ããæ¹æ³ãšåæ§ãªæ¹æ³ã§è£œé ãã
ããšãã§ãããããšãã°ïŒâïŒ1HâïŒïŒïŒïŒïŒ
âããªã¢ãŸãŒã«âïŒâã€ã«ïŒâ2â²ïŒ4â²âãžã¯ã
ã«ã¢ã»ãããšãã³ãïŒâããã â2â²ïŒ4â²âãžã¯
ãã«ã¢ã»ãããšãã³ãïŒïŒïŒïŒïŒâããªã¢ãŸãŒ
ã«ããã³çé žã«ãªãŠã ãã補é ããããšã«ã€ã
ãŠã¯è±åœç¹èš±ç¬¬1512918å·æ现æžã®äŸïŒã«èšèŒ
ãããŠããããã®æ¹æ³ã¯æº¶å€ãšããŠã¢ã»ããã
ãªã«ãéæµäžã«20æé䜿çšãããæ¬çºæè ã
ã¯ããã®åã®åå¿ãäžè¬ã«ã¢ã»ãã³äžïŒã20â
ã§è¡ãããšãæè¯ã§ããããã®å Žåããã¯äžè¬
ã«æ¯èŒççæéïŒããšãã°ïŒæéïŒã§çµäºãã
ããšãèŠåºããã åŒã®è€çŽ ç°åŒããªãŒã«ã¯äžè¬ã«æ¢ç¥ã®åå
ç©ã§ãããããŸãã¯ãããã¯å®¹æã«åŸãããåº
çºç©è³ªããéåžžã®åå¿ã«ãã補é ãããã (2) ïœãïŒïŒã¹ã«ããã·ãïŒããã³ïŒïŒã¹ã«ãã³ïŒ
ã§ããåŒïŒïŒã®ååç©ã¯ãïœãïŒã§ãã察å¿
ããååç©ã®ããããå¶åŸ¡ãããé žåãŸãã¯åŒ·
ãé žåã«ãã補é ããããšãã§ãããïœãïŒã§
ããååç©ã¯ãïœãïŒã§ããååç©ã®é žåã«ã
ã€ãŠè£œé ããããšãã§ããã 奜ãŸããé žåå€ã¯ïœâã¯ãã«éå®æ¯éŠé žã§ã
ããã¹ã«ããã·ãã補é ããããã«ã¯çŽïŒåœé
ããã¹ã«ãã³ã補é ããããã«ã¯éå°éã䜿çš
ãã¹ãã§ããã ã¹ã«ããã·ãã®è£œé ã䌎ãäžè¬çæ¹æ³ã«ãã
ãŠã¯å¯Ÿå¿ããããªååç©ãã€ãœãããããŒã«ãš
ã¯ãããã«ã ã®æ··åç©ïŒïŒïŒïŒãïŒïŒ¶ïŒã«æº¶
解ãã溶液ã氷济äžã§ïŒâ以äžã«å·åŽãããïŒ
åœéããããããã«å°ãªãéã®ïœâã¯ãã«éå®
æ¯éŠé žãæ°åéã«ããã€ãŠå°éãã€æ·»å ããã®
ã¡æ··åç©ãçŽïŒæéæªæãããèå±€ã¯ãããã°
ã©ãã€ãŒã«ãã€ãŠæªåå¿ã®åºçºç©è³ªã®ããããš
ã瀺ãããå Žåãå°éã®ïœâã¯ãã«éå®æ¯éŠé ž
ïŒïŒåœéãŸã§ïŒãè¿œå ãããã¹ã«ããã·ãã¯ïŒ
åã®äžæŽäžå¿ããã€ã®ã§ãïŒçš®ã®ãžã¢ã¹ãã¬ãª
ããŒã®åœ¢ã§ååšãããåŸã€ãŠé žåã«ããçæç©
ã¹ã«ããã·ãïŒåžžæ³ã«ããåé¢ããããšãã§ã
ãïŒã¯ïŒçš®ã®ãžã¢ã¹ãã¬ãªããŒã®æ··åç©ã§ãã
ããéåžžãããã®ãžã¢ã¹ãã¬ãªããŒã¯æ¥µæ§ãç°
ãªãã®ã§ãææã«ããã«ã©ã ã¯ãããã°ã©ãã€
ãŒã«ããåé¢ããããšãã§ãããã¹ã«ãã³ã¯å
ã«ç²è£œã¹ã«ããã·ã溶液ã«éå°ã®ïœâã¯ãã«é
å®æ¯éŠé žãæ·»å ãã宀枩ã§æ°æéæªæããããš
ã«ãã€ãŠåŸãããããããã¯éå°ã®ïœâã¯ãã«
éå®æ¯éŠé žãçšããŠããªååç©ïŒïœïŒïŒïŒãé ž
åããããšã«ãã€ãŠã¹ã«ãã³ã補é ããããšã
ã§ããã (3) è€çŽ ç°ãŸãã¯çž®åããšãã«ç°ã眮æåºãå«ã
å ŽåãåçŽãªèªå°äœããã³é¢é£ååç©ã補é ã
ãããã«éåžžã®ååŠçå€æåå¿ãæ¡çšããããš
ãã§ããã ããšãã°è€çŽ ç°ãã¢ããåºãå«ãå Žåãéåžž
ã®ã¢ã»ãã«ååå¿ïŒããšãã°ããªãžã³äžã®ç¡æ°Ž
é ¢é žãçšããŠïŒãæ¡çšããŠãâã¢ã»ãã«èªå°
äœã補é ããããšãã§ãããä»ã®å€æåå¿ãã
ã³ããããå®æœããããã«å¿ èŠãªæ¡ä»¶ã¯åœæ¥è
ã«åšç¥ã§ãããã ïœïŒïŒã§ããåŒïŒïŒã¹ã«ããã·ãã¯ïŒåã®
äžæŽäžå¿ãããªãã¡æ°Žé žåºãæã€ççŽ ååãã
ã³ã¹ã«ããã·ãã®ã€ãªãŠååããã€ãåŸã€ãŠã¹
ã«ããã·ãã¯ïŒåã®ãžã¢ã¹ãã¬ãªããŒã®åœ¢ã§å
åšãããã®åã ã¯ïŒå¯Ÿã®å åŠç察æäœãããªã
ã©ã»ãäœã§ããããããïŒå¯Ÿã®ãžã¢ã¹ãã¬ãªã
ãŒã¯æ¥µæ§ãç°ãªãã®ã§ãã«ã©ã ã¯ãããã°ã©ã
ã€ãŒã«ãã€ãŠå®¹æã«åé¢ããããšãã§ãããå
ãžã¢ã¹ãã¬ãªããŒå¯Ÿã¯åœæ¥è ã®æ¢ç¥ã®æ¹æ³ã§ã
ãã«ãã®åã ã®å åŠæŽ»æ§ã¯å åŠç察æäœã«åå²
ããããšãã§ãããããå Žåã«ã¯ãïŒå¯Ÿã®ãžã¢
ã¹ãã¬ãªããŒãä»æ¹ãããåªå¢ã§ãããæ¬çºæ
ã«ã¯åå²ããããŸãã¯åå²ãããŠããªãåãžã¢
ã¹ãã¬ãªããŒå¯Ÿãå«ãŸããã æ¬çºæã®ååç©ã¯ãã¹ãŠå°ãªããšãïŒåã®ã
ã©ãŒã«äžå¿ããã¡ãæ¬çºæã«ã¯åå²ããã圢ã
ãã³åå²ãããŠããªã圢ã®åæ¹ãå«ãŸããã åŒïŒïŒã®ååç©ã®è¬åŠçã«å容ã§ããé žä»
å å¡©ã«ã¯ç¡æ¯æ§ã®é žä»å å¡©ã圢æããåŒ·é žãã
ãšãã°å¡©é žãèåæ°ŽçŽ é žãç¡«é žãç¡é žãã·ãŠãŠ
é žããã³ã¡ã¿ã³ã¹ã«ãã³é žãã圢æããããã®
ãå«ãŸããã ãããã®å¡©ã¯åžžæ³ã«ãããããšãã°åœã¢ã«éã®
éé¢å¡©åºããã³åžæããé žãå«æãã溶液ãæ··å
ããå¿ èŠãªå¡©ãäžæº¶æ§ã§ããå Žåã«ã¯ãããé
ã«ããæ¡åãããŸãã¯æº¶å€ã®èžçºã«ããæ¡åã
ãã åŒïŒïŒã®ååç©ããã³ãããã®è¬åŠçã«å容
ã§ããå¡©ã¯ããããå«ãåç©ã«ãããŠçèææã«
察åŠããã®ã«æçšãªæçèè¬ã§ãããããšãã°ã
ããã¯ããã«ãããŠãšãããã«ã³ãžãå±
ïŒCandidaïŒãããªã³ãã€ãã³å±ïŒTricophytonïŒã
ãã¯ãã¹ãã«ã å±ïŒMicrosporumïŒãããã¯ãš
ããã«ã¢ãã€ãã³å±ïŒEpidermophytonïŒã®èçš®
ã«ãã€ãŠèµ·ããå±æçãªçèææã®æ²»çããŸãã¯
ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ïŒCandida albicansïŒ
ã«ãã€ãŠèµ·ããç²èææïŒããšãã°å£è ã«ã³ãžã
çããã³è ã«ã³ãžãçïŒã«æçšã§ããããããã¯
ãŸãããšãã°ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã»ã¯ãªãã
ã³ãã¯ã¹ã»ããªãã«ãã³ã¹ïŒCryptococcus
neoformansïŒãã¢ã¹ãã«ã®ã«ã¹ã»ããã¬ãŒã¿ã¹
ïŒAsperqillvs fumigatusïŒãã³ã¯ã·ãžãªã€ãã¹
ïŒCoccidioidesïŒããã©ã³ã¯ãžãžãªã€ãã¹å±
ïŒParacoccidioidesïŒããã¹ããã©ã¹ãå±
ïŒHistoplasmaïŒãŸãã¯ãã©ã¹ããã»ã¹å±
ïŒBlastomycesïŒã®èã«ãã€ãŠèµ·ããå šèº«æ§çè
ææã®æ²»çã«éããŠå šèº«çã«çšããããšãã§ã
ãã ååç©ã®æçè掻æ§ã®ã€ã³ãããè©äŸ¡ã¯ãé©å
ãªå¹å°ã«ãããŠç¹å®ã®åŸ®çç©ãçºè²ã§ããªããªã
被éšååç©ã®æå°çºè²é»æ¢æ¿åºŠïŒm.i.c.ïŒãå€å®
ããããšã«ãã€ãŠè¡ãããšãã§ãããå®éã«ã¯ã
ããããç¹å®æ¿åºŠã®è¢«éšååç©ãå«æããäžé£ã®
å¯å€©å¹³æ¿ã«ããšãã°ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã®æš
æºå¹é€ç©ãæ¥çš®ãã次ãã§åå¹³æ¿ã37âã§48æé
ã€ã³ããŠããŒãããã次ãã§çèçºè²ã®æç¡ã«ã€
ãå¹³æ¿ãæ€æ»ããé©å®ãªæå°çºè²é»æ¢æ¿åºŠãèšé²
ããããã®çš®ã®è©Šéšã«çšããããä»ã®åŸ®çç©ã«ã¯
ã¯ãªããã³ãã¯ã¹ã»ããªãã«ãã³ã¹ãã¢ã¹ãã«ã®
ã«ã¹ã»ããã¬ãŒã¿ã¹ãããªã³ãã€ãã³å±èããã¯
ãã¹ãã«ã å±èããšããã«ã¢ãã€ãã³ã»ãããã³
ãµã ïŒEpidermophyton floccosumïŒãã³ã¯ã·ãž
ãªã€ãã¹ã»ã€ããã¹ïŒC.immitisïŒããã³ãã«ã
ãã·ã¹ã»ã°ã©ãã©ãŒã¿ïŒTorulopsis glabrataïŒ
ãå«ãŸããã ååç©ã®ã€ã³ããè©äŸ¡ã¯ãã«ã³ãžãã»ã¢ã«ãã«
ã³ã¹ã®èæ ªãæ¥çš®ãããããŠã¹ã«äžé£ã®çšéæ°Žæº
ã§è ¹è å ãŸãã¯éèå ã«æ³šå°ããããšã«ãã€ãŠè¡
ãããšãã§ããã掻æ§ã¯48æéã®èŠ³å¯åŸã«æªåŠç
ã°ã«ãŒãã®ããŠã¹ãæ»äº¡ããã®ã¡ã®åŠçã°ã«ãŒã
ã®ããŠã¹ã®çåæ°ã«åºã¥ããã®ã§ãããååç©ã
ææã®èŽæ»äœçšã«å¯ŸããŠ50ïŒ ã®é²åŸ¡ã瀺ããçšé
æ°Žæºãèšé²ããã ããã«çšããããã«ã¯åŒïŒïŒã®æçèæ§åå
ç©ãåç¬ã§æäžããããšãã§ããããäžè¬ã«ã¯æ
å³ããæäžçµè·¯ããã³æšæºçãªè¬åŠçå®å°ã«é¢é£
ããŠéžã°ããè¬å€ãã€ãªã€ãŒãšã®æ··åç©ãšããŠæ
äžãããã§ããããããšãã°ãããã¯ãã³ãã³ã
ããã¯ä¹³ç³ãªã©ã®è³Šåœ¢å€ãå«æããé å€ã®åœ¢ã§ã
ãŸãã¯ã«ãã»ã«ãããã¯åµåœ¢å€äžã§åç¬ã§ããã
ã¯è³Šåœ¢å€ãšã®æ··åç©ãšããŠããŸãã¯ç¯å³å€ããã
ã¯çè²å€ãå«æãããšãªãã·ã«å€ãããã¯æžæ¿å€
ã®åœ¢ã§çµå£æäžããããšãã§ãããããããéçµ
å£çã«ãããšãã°éèå ãçèå ãŸãã¯ç®äžã«æ³š
å°ããããšãã§ãããéçµå£æäžã®ããã«ã¯ãä»
ã®ç©è³ªïŒããšãã°æº¶æ¶²ãç匵ã«ããã®ã«ååãª
å¡©ïŒãå«æããŠããŠãããæ» è氎溶液ã®åœ¢ã§ãã
ããçšããããšãæè¯ã§ããã æ£è ã«çµå£ãŸãã¯éçµå£æäžããããã«ã¯ãåŒ
ïŒïŒã®æçèæ§ååç©ã®ïŒæ¥éã¯çµå£çãŸãã¯
éçµå£ççµè·¯ã«ããæäžããé0.1ã10mgïŒKg
ïŒåå²æäžïŒã§ããããšäºæ³ããããããšãã°æ¬
ååç©ã®é å€ãŸãã¯ã«ãã»ã«å€ã¯ãé©æïŒåãªã
ããã以äžã®æäžã®ããïŒmgã0.5ïœã®æŽ»æ§åå
ç©ãå«æãããšäºæ³ããããšãã§ãããå»åž«ã¯ã
ããã«ããæ£è å人ã«æé©ãšæãããå®éã®çšé
ãå€å®ããã§ããããããã¯ãã®æ£è ã®å¹Žä»€ãäœ
éããã³åå¿ã«å¿ããŠå€åããã§ããããåèšã®
çšéã¯å¹³åççäŸã®äžäŸã§ããããã¡ããããã
ããé«ãããŸãã¯äœãçšéç¯å²ãæå©ã§ããåã
ã®äŸãããããããããã¯æ¬çºæã®ç¯å²ã«å å«ã
ããã ãããã¯åŒïŒïŒã®æçèæ§ååç©ãåå€ãŸã
ã¯ãããµãªãŒã®åœ¢ã§æçšããããããŒã·ãšã³ã溶
液ãã¯ãªãŒã ãè»ãããŸãã¯æ£ç²å€ã®åœ¢ã§å±ææ
äžããããšãã§ãããããšãã°ãããã¯ããªãšã
ã¬ã³ã°ãªã³ãŒã«ãŸãã¯æµåãã©ãã€ã³ã®æ°Žæ§ãšã
ã«ãžãšã³ãããªãã¯ãªãŒã ã«å«æããããããã
ãã¯å¿ èŠãªå®å®å€ããã³ä¿åå€ãšå ±ã«çœãããŸã
ã¯çœè²è»ããåºå€ãããªãè»ããã«ïŒã10ïŒ ã®æ¿
床ã§å«æãããããšãã§ããã æ¬ååç©ã¯ãçèææãæ ¹çµ¶ãããŸãã¯äºé²ã
ãããã«æ€ç©ããã³çš®åãåŠçãã蟲æ¥çšã®æ®ºç
èè¬ãšããŠãæçšã§ããã 以äžã®å®æœäŸã¯æ¬çºæãå ·äœçã«èª¬æãããã®
ã§ããã å®æœäŸ ïŒ ïŒâãïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâ
ããããã·âïŒâïŒïŒïŒïŒïŒïŒâããªã¢ãŸãŒã«
âïŒâã€ã«ããªïŒâãããã«ãâïŒïŒïŒïŒïŒâã
ãªã¢ãŸãŒã« ïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâïŒ1Hâ
ïŒïŒïŒïŒïŒâããªã¢ãŸãŒã«âïŒâã€ã«ã¡ãã«ïŒâ
ãªãã·ã©ã³ã»ã¡ã¿ã³ã¹ã«ãã³é žå¡©ïŒïœïŒ0.0137ã¢
ã«ïŒãïŒâã¡ã«ã«ããâïŒïŒïŒïŒïŒâããªã¢ãŸãŒ
ã«ïŒïœïŒ0.05ã¢ã«ïŒããã³ç¡æ°Žçé žã«ãªãŠã 14ïœ
ïŒ0.1ã¢ã«ïŒã也ç¥ãžã¡ãã«ãã«ã ã¢ãã100mläž
ã§80âã«ãããŠïŒæéæªæããã次ãã§æº¶å€ãèž
çºãããæ®æ»ãæ°Žã«æº¶è§£ããå¡©åã¡ãã¬ã³ã§æœåº
ãããæœåºæ¶²ã«åãããŠåžçé žæ°ŽçŽ ãããªãŠã 溶
液ã§ïŒåæŽæµãã也ç¥ããïŒMgSO4ïŒãèžçºãã
ãŠãåºäœæ®æ»ãåŸãããããã€ãœãããããŒã«ïŒ
æ°Žããåçµæ¶ããŠè¡šé¡ã®ååç©3.7ïœïŒ74ïŒ ïŒã
åŸããèç¹180ã182âã å çŽ åæïŒïŒ ïŒïŒ å®æž¬å€ïŒïŒ£ïŒ42.29ïŒïŒšïŒ3.30ïŒïŒ®ïŒ22.86 çè«å€ïŒC13H12N6OSCl2 ïŒ42.07ïŒïŒšïŒ3.26ïŒïŒ®ïŒ22.64 å®æœäŸ ïŒ ïŒâãïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâ
ããããã·âïŒâïŒïŒâã¡ãã«ã€ãããŸãŒã«â
ïŒâã€ã«ããªïŒâãããã«ãâïŒïŒïŒïŒïŒâããª
ã¢ãŸãŒã« ïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâïŒ1Hâ
ïŒïŒïŒïŒïŒâããªã¢ãŸãŒã«âïŒâã€ã«ã¡ãã«ïŒâ
ãªãã·ã©ã³0.27ïœïŒ0.001ã¢ã«ïŒããã³ïŒâã¡ã«
ã«ããâïŒâã¡ãã«ã€ãããŸãŒã«0.228ïœïŒ0.002
ã¢ã«ïŒããžãªããµã³äžã§éæµäžã«72æéå ç±ã
ãã次ãã§ãžãªããµã³ãèžçºãããæ®æ»ãé ¢é žãš
ãã«70mlã«æº¶è§£ããã溶液ãåžçé žã«ãªãŠã 溶
液ãåžæ°Žé žåãããªãŠã 溶液ã§é 次æŽæµãã也ç¥
ããïŒMgSO4ïŒãèžçºãããŠãæ²¹ãåŸããããã¯
æŸçœ®ãããšçµæ¶åãããé ¢é žãšãã«ïŒãããµã³ã
ãåçµæ¶ããŠãè¡šé¡ã®ååç©0.252ïœïŒ66ïŒ ïŒã
åŸããèç¹159ã161âã å çŽ åæïŒïŒ ïŒïŒ å®æž¬å€ïŒïŒ£ïŒ46.97ïŒïŒšïŒ3.84ïŒïŒ®ïŒ18.62 çè«å€ïŒC15H15N5OSCl2 ïŒ46.88ïŒïŒšïŒ3.93ïŒïŒ®ïŒ18.23 å®æœäŸ ïŒ ïŒâãïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâ
ããããã·âïŒâïŒãã¢ãŸãŒã«âïŒâã€ã«ããªïŒ
âãããã«ãâïŒïŒïŒïŒïŒâããªã¢ãŸãŒã« ïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâïŒ1Hâ
ïŒïŒïŒïŒïŒâããªã¢ãŸãŒã«âïŒâã€ã«ã¡ãã«ïŒâ
ãªãã·ã©ã³ã»ã¡ã¿ã³ã¹ã«ãã³é žå¡©ïŒïœïŒ0.0164ã¢
ã«ïŒããã³ïŒâã¡ã«ã«ãããã¢ãŸãŒã«ïŒïœïŒ0.05
ã¢ã«ïŒãæ°·é ¢é ž200mläžã§éæµäžã«ïŒæéå ç±ã
ãã次ãã§æº¶å€ãèžçºãããæ®æ»ãåžæ°Žé žåãã
ãªãŠã 溶液ã§å¡©åºæ§ãšãªããå¡©åã¡ãã¬ã³ã§æœåº
ãããæœåºæ¶²ãåžæ°Žé žåãããªãŠã 溶液ã§ïŒåæŽ
æµãã也ç¥ããïŒïŒïœSO4ïŒãèžçºãããŠãæ·¡è€
è²ã¬ã©ã¹æ§ç©è³ª5.4ïœãåŸãããããã·ãªã«äžã§
é ¢é žãšãã«ïŒãšãŒãã«ïŒã¡ã¿ããŒã«ïŒãžãšãã«ã¢
ãã³25ïŒ75ïŒïŒïŒïŒã«ãã溶é¢ãããŠã¯ãããã°
ã©ãã€ãŒåŠçããã€ãœãããããŒã«ããïŒååçµ
æ¶ããã®ã¡ãè¡šé¡ã®ååç©ïŒïœïŒ32ïŒ ïŒãåŸãã
èç¹110ã111âã å çŽ åæïŒïŒ ïŒïŒ å®æž¬å€ïŒïŒ£ïŒ43.36ïŒïŒšïŒ3.12ïŒïŒ®ïŒ14.83 çè«å€ïŒC14H11N4OS2Cl2 ïŒ43.43ïŒïŒšïŒ3.12ïŒïŒ®ïŒ14.47 å®æœäŸ ïŒã19 å®æœäŸïŒãïŒã«èšèŒããäžè¬çæ¹æ³ã«ãããã
ã ãé©å®ãªè€çŽ ç°åŒããªãŒã«ãçšããŠãäžèšã®å
åç©ã補é ããã
ã«ãããŠçèææã®æ²»çã«æçšã§ããæ°èŠãªããª
ã¢ãŸãŒã«èªå°äœã«é¢ããã æ¬çºæã«ããã°ãæ¬¡åŒ ïŒåŒäžArã¯ïŒïŒïŒâãžããããšãã«åºã§ããã ïœã¯ïŒãŸãã¯ïŒã§ããã Hetã¯ïŒâã€ãããŸãªã«åºãïŒâãã¢ãŸãªã«
åºãïŒâïŒïŒïŒïŒïŒïŒâããªã¢ãŸãªã«ïŒåºãïŒâ
ããã©ãŸãªã«åºãïŒâïŒïŒïŒïŒïŒïŒâãã¢ãžã¢ãŸ
ãªã«åºïŒãïŒâãïŒâãããã¯ïŒâããªãžã«åºã
ïŒâãããã¯ïŒâããªããžãã«åºããããªã«åºã
ãã³ãŸãã¢ãŸãªã«åºãŸãã¯ããªãã«åºã§ãããã
ãããè€çŽ ç°ãŸãã¯çž®åããšãã«ç°ã«ãããŠïŒå
ãŸãã¯ãã以äžã®ããã²ã³ãCF3ãC1âC4ã¢ã«ã
ã«åºãC1âC4ã¢ã«ã³ãã·åºãã¢ããåºãã¢ãã
ããã¯ãžC1âC4ã¢ã«ãã«âã¢ããåºãã¢ã«ã«ã
ã€ã«ã¢ããåºãæ°Žé žåºãŸãã¯ããªåºã«ãã眮æã
ããŠããŠãããïŒ ã®ååç©ããã³è¬å€åŠçã«å容ã§ãããããã®å¡©
ãæäŸãããã Arã¯å¥œãŸããã¯ïŒïŒïŒâãžã¯ãã«ããšãã«åº
ã§ããã 奜ãŸããè€çŽ ç°æ®åºã«ã¯ã€ãããŸãªã«åºãããª
ããžãã«åºããã³ãã¢ãŸãªã«åºãç¹ã«ïŒâã€ãã
ãŸãªã«åºãïŒâïŒïŒâã¡ãã«âã€ãããŸãªã«åºïŒã
ïŒâãã¢ãŸãªã«åºããªãã³ã«ïŒâããã³ïŒâããª
ããžãã«åºãå«ãŸããã ã¢ã«ãã«åºãã¢ã«ã³ãã·åºããã³ã¢ã«ã«ãã€ã«
åºã¯é©å®çŽéã§ãã€ãŠãåæéã§ãã€ãŠãããã æ¬çºæã¯ãåŒïŒïŒã®ååç©ãããã¯è¬åŠçã«
å容ã§ãããããã®å¡©ãããã³è¬åŠçã«å容ã§ã
ãåžéå€ãããã¯ãã€ãªã€ãŒãå«ãè¬å€çµæç©ã
æäŸããã ããã«æ¬çºæã¯ããããå«ãåç©ã«ãããŠçè
ææã®æ²»çã«äœ¿çšããããã®åŒïŒïŒã®ååç©ãŸ
ãã¯è¬åŠçã«å容ã§ãããããã®å¡©ãæäŸããã åŒïŒïŒã®ååç©ã¯æ¬çºæã«åŸã€ãŠå€çš®ã®æ¹æ³
ã«ããåŸãããšãã§ããã ïŒ äžæ¹æ³ã«ãããŠã¯ãïœãïŒã§ããåŒïŒïŒã®
ååç©ãæ¬¡åŒ ã®ãªãã·ã©ã³ããæ¬¡åŒ HetâSH ⊠ã®è€çŽ ç°åŒããªãŒã«ïŒãããã®åŒäžArããã³
Hetã¯å ãã«å®çŸ©ããããã®ã§ããïŒãšã®åå¿
ã«ãã€ãŠè£œé ããããšãã§ããã ãã®åå¿ã¯ãããçšåºŠã¯åå¿é¢äžäœã®å³å¯ãª
æ§è³ªã«å¿ããŠå€æ§ãªæ¡ä»¶äžã§éæããããäžè¬
ã«åžžæ³ã«ãããªãã·ã©ã³ïŒïŒããã®éé¢å¡©åº
ãšããŠãææ©æº¶å€ããšãã°ãžãªããµã³äžã§éå°
ã®è€çŽ ç°åŒããªãŒã«ïŒïŒãšå ±ã«å ç±ããããš
ã«ãã€ãŠåå¿ãè¡ãããšãã§ãããéæµæž©åºŠã§
ïŒæ¥ãŸã§ã®æéã§äžè¬ã«ååã§ãããã觊åªé
ã®åžæ°Žé žåãããªãŠã 溶液ã®æ·»å ã«ãã€ãŠãã°
ãã°åçãæ¹åãããåå¿æéãççž®ãããã
çæç©ã¯åžžæ³ã«ãããããšãã°æº¶å€ãèžçºã
ããçæç©ãæ°Žãšæ··åãããææ©æº¶å€ã«å ¥ãã
çæç©ãäœæ¿åºŠã®æ°Žé žåãããªãŠã ãŸãã¯çé ž
ã«ãªãŠã ã®æº¶æ¶²ã§æœåºããæªåå¿ããªãŒã«ãé€
å»ãã也æããã溶å€ãèžçºãããããšã«ãã€
ãŠåé¢ã粟補ããããšãã§ãããçæç©ã¯ææ
ã«ããçµæ¶åãŸãã¯ã¯ãããã°ã©ãã€ãŒã«ãã€
ãŠããã«ç²Ÿè£œããããšãã§ããã 代æ¿æ³ãšããŠã¯ããªãã·ã©ã³ïŒãã®ã¡ã¿ã³ã¹
ã«ãã³é žå¡©ãšããŠïŒããã³è€çŽ ç°åŒããªãŒã«ã
å ±ã«ææ©æº¶åªïŒããšãã°ïŒ®ïŒïŒ®âãžã¡ãã«ãã«
ã ã¢ãããŸãã¯ããã©ããããã©ã³ïŒäžã§å¡©åº
ããšãã°çé žã«ãªãŠã ãŸãã¯æ°ŽçŽ åãããªãŠã
ã®ååšäžã«å ç±ããã60ã80âã®æž©åºŠãäžè¬ã«
çšãããããããã®æ¡ä»¶äžã§åå¿ã¯äžè¬ã«æ°æ
é以å ã«å®è³ªçã«çµäºãããçæç©ã¯åèšã®ã
ãã«åé¢ã粟補ãããã ä»ã®å€æ³ãšããŠããªãã·ã©ã³ããã®ã¡ã¿ã³ã¹
ã«ãã³é žå¡©ãšããŠéå°ã®è€çŽ ç°åŒããªãŒã«ãšå ±
ã«éæµäžã«æ°·é ¢é žäžã§æ°æéå ç±ããã ãªãã·ã©ã³ïŒïŒã¯åžžæ³ã«ãããäžè¬ã«å¯Ÿå¿
ããã±ãã³ïŒïŒ ãããžã¡ãã«ãªããœã¹ã«ãããŠã ã¡ããªãŒã
ïŒãšãŠåããªã¡ãã«ã¹ã«ãããœããŠã ãããžã¡
ãã«ã¹ã«ããã·ãäžã®æ°ŽçŽ åãããªãŠã ããã
ã¯æ°Žããã³ãã«ãšã³ã®æ··åç©äžã®ã»ããªãã
ïŒcetrimideïŒããã³æ°Žé žåãããªãŠã ãçšããŠ
補é ããããã®ïŒãšã®åå¿ã«ããåŸãããšãã§
ããã æ°ŽçŽ åãããªãŠã ãçšããåå¿ã¯äžè¬ã«ä¹Ÿç¥
ç²æ«ç¶ã®ãšãŠåããªã¡ãã«ã¹ã«ãããœããŠã ã
ãžã¡ãã«ã¹ã«ããã·ãäžã®æ°ŽçŽ åãããªãŠã æž
æ¿æ¶²ã«æ·»å ããããšã«ãã€ãŠéæãããã宀枩
ã§ããšãã°30åéæªæããã®ã¡ãã±ãã³ïŒïŒ
ããžã¡ãã«ã¹ã«ããã·ãäžã§ã»ãŒåœã¢ã«éæ·»å
ãããåå¿æ··åç©ãå æž©ããŠåå¿ãä¿é²ããã
ããšãã§ãã50ã80âã§æ°æéåŸã«åžžæ³ã«ãã
çæç©ãåé¢ããããšãã§ããã ã»ããªãããçšããåå¿ã¯äžè¬ã«ã±ãã³
ïŒïŒããšãŠåããªã¡ãã«ã¹ã«ãããœããŠã ãã
ã³ã»ããªããããã«ãšã³ããã³æ°Žé žåãããªãŠ
ã ã®æ··åç©äžã§çŽïŒæéãçŽ100â以äžã§äºã
ã«æ¿ããæªæããããšã«ãã€ãŠéæãããã次
ãã§åžžæ³ã«ããçæç©ãªãã·ã©ã³ãåé¢ããã
ãšãã§ããã Arããªã«ã眮æåºãå«ãŸãªãããšãã«åºã§
ããããŸãã¯ãããšããªã«åºã§ããå Žåãã»ã
ãªããçµè·¯ãæ¡çšãã¹ãã§ããã ã±ãã³ïŒïŒã¯æ¢ç¥ã®ååç©ã§ãããããŸã
ã¯å è¡æè¡ã«ããæ¹æ³ãšåæ§ãªæ¹æ³ã§è£œé ãã
ããšãã§ãããããšãã°ïŒâïŒ1HâïŒïŒïŒïŒïŒ
âããªã¢ãŸãŒã«âïŒâã€ã«ïŒâ2â²ïŒ4â²âãžã¯ã
ã«ã¢ã»ãããšãã³ãïŒâããã â2â²ïŒ4â²âãžã¯
ãã«ã¢ã»ãããšãã³ãïŒïŒïŒïŒïŒâããªã¢ãŸãŒ
ã«ããã³çé žã«ãªãŠã ãã補é ããããšã«ã€ã
ãŠã¯è±åœç¹èš±ç¬¬1512918å·æ现æžã®äŸïŒã«èšèŒ
ãããŠããããã®æ¹æ³ã¯æº¶å€ãšããŠã¢ã»ããã
ãªã«ãéæµäžã«20æé䜿çšãããæ¬çºæè ã
ã¯ããã®åã®åå¿ãäžè¬ã«ã¢ã»ãã³äžïŒã20â
ã§è¡ãããšãæè¯ã§ããããã®å Žåããã¯äžè¬
ã«æ¯èŒççæéïŒããšãã°ïŒæéïŒã§çµäºãã
ããšãèŠåºããã åŒã®è€çŽ ç°åŒããªãŒã«ã¯äžè¬ã«æ¢ç¥ã®åå
ç©ã§ãããããŸãã¯ãããã¯å®¹æã«åŸãããåº
çºç©è³ªããéåžžã®åå¿ã«ãã補é ãããã (2) ïœãïŒïŒã¹ã«ããã·ãïŒããã³ïŒïŒã¹ã«ãã³ïŒ
ã§ããåŒïŒïŒã®ååç©ã¯ãïœãïŒã§ãã察å¿
ããååç©ã®ããããå¶åŸ¡ãããé žåãŸãã¯åŒ·
ãé žåã«ãã補é ããããšãã§ãããïœãïŒã§
ããååç©ã¯ãïœãïŒã§ããååç©ã®é žåã«ã
ã€ãŠè£œé ããããšãã§ããã 奜ãŸããé žåå€ã¯ïœâã¯ãã«éå®æ¯éŠé žã§ã
ããã¹ã«ããã·ãã補é ããããã«ã¯çŽïŒåœé
ããã¹ã«ãã³ã補é ããããã«ã¯éå°éã䜿çš
ãã¹ãã§ããã ã¹ã«ããã·ãã®è£œé ã䌎ãäžè¬çæ¹æ³ã«ãã
ãŠã¯å¯Ÿå¿ããããªååç©ãã€ãœãããããŒã«ãš
ã¯ãããã«ã ã®æ··åç©ïŒïŒïŒïŒãïŒïŒ¶ïŒã«æº¶
解ãã溶液ã氷济äžã§ïŒâ以äžã«å·åŽãããïŒ
åœéããããããã«å°ãªãéã®ïœâã¯ãã«éå®
æ¯éŠé žãæ°åéã«ããã€ãŠå°éãã€æ·»å ããã®
ã¡æ··åç©ãçŽïŒæéæªæãããèå±€ã¯ãããã°
ã©ãã€ãŒã«ãã€ãŠæªåå¿ã®åºçºç©è³ªã®ããããš
ã瀺ãããå Žåãå°éã®ïœâã¯ãã«éå®æ¯éŠé ž
ïŒïŒåœéãŸã§ïŒãè¿œå ãããã¹ã«ããã·ãã¯ïŒ
åã®äžæŽäžå¿ããã€ã®ã§ãïŒçš®ã®ãžã¢ã¹ãã¬ãª
ããŒã®åœ¢ã§ååšãããåŸã€ãŠé žåã«ããçæç©
ã¹ã«ããã·ãïŒåžžæ³ã«ããåé¢ããããšãã§ã
ãïŒã¯ïŒçš®ã®ãžã¢ã¹ãã¬ãªããŒã®æ··åç©ã§ãã
ããéåžžãããã®ãžã¢ã¹ãã¬ãªããŒã¯æ¥µæ§ãç°
ãªãã®ã§ãææã«ããã«ã©ã ã¯ãããã°ã©ãã€
ãŒã«ããåé¢ããããšãã§ãããã¹ã«ãã³ã¯å
ã«ç²è£œã¹ã«ããã·ã溶液ã«éå°ã®ïœâã¯ãã«é
å®æ¯éŠé žãæ·»å ãã宀枩ã§æ°æéæªæããããš
ã«ãã€ãŠåŸãããããããã¯éå°ã®ïœâã¯ãã«
éå®æ¯éŠé žãçšããŠããªååç©ïŒïœïŒïŒïŒãé ž
åããããšã«ãã€ãŠã¹ã«ãã³ã補é ããããšã
ã§ããã (3) è€çŽ ç°ãŸãã¯çž®åããšãã«ç°ã眮æåºãå«ã
å ŽåãåçŽãªèªå°äœããã³é¢é£ååç©ã補é ã
ãããã«éåžžã®ååŠçå€æåå¿ãæ¡çšããããš
ãã§ããã ããšãã°è€çŽ ç°ãã¢ããåºãå«ãå Žåãéåžž
ã®ã¢ã»ãã«ååå¿ïŒããšãã°ããªãžã³äžã®ç¡æ°Ž
é ¢é žãçšããŠïŒãæ¡çšããŠãâã¢ã»ãã«èªå°
äœã補é ããããšãã§ãããä»ã®å€æåå¿ãã
ã³ããããå®æœããããã«å¿ èŠãªæ¡ä»¶ã¯åœæ¥è
ã«åšç¥ã§ãããã ïœïŒïŒã§ããåŒïŒïŒã¹ã«ããã·ãã¯ïŒåã®
äžæŽäžå¿ãããªãã¡æ°Žé žåºãæã€ççŽ ååãã
ã³ã¹ã«ããã·ãã®ã€ãªãŠååããã€ãåŸã€ãŠã¹
ã«ããã·ãã¯ïŒåã®ãžã¢ã¹ãã¬ãªããŒã®åœ¢ã§å
åšãããã®åã ã¯ïŒå¯Ÿã®å åŠç察æäœãããªã
ã©ã»ãäœã§ããããããïŒå¯Ÿã®ãžã¢ã¹ãã¬ãªã
ãŒã¯æ¥µæ§ãç°ãªãã®ã§ãã«ã©ã ã¯ãããã°ã©ã
ã€ãŒã«ãã€ãŠå®¹æã«åé¢ããããšãã§ãããå
ãžã¢ã¹ãã¬ãªããŒå¯Ÿã¯åœæ¥è ã®æ¢ç¥ã®æ¹æ³ã§ã
ãã«ãã®åã ã®å åŠæŽ»æ§ã¯å åŠç察æäœã«åå²
ããããšãã§ãããããå Žåã«ã¯ãïŒå¯Ÿã®ãžã¢
ã¹ãã¬ãªããŒãä»æ¹ãããåªå¢ã§ãããæ¬çºæ
ã«ã¯åå²ããããŸãã¯åå²ãããŠããªãåãžã¢
ã¹ãã¬ãªããŒå¯Ÿãå«ãŸããã æ¬çºæã®ååç©ã¯ãã¹ãŠå°ãªããšãïŒåã®ã
ã©ãŒã«äžå¿ããã¡ãæ¬çºæã«ã¯åå²ããã圢ã
ãã³åå²ãããŠããªã圢ã®åæ¹ãå«ãŸããã åŒïŒïŒã®ååç©ã®è¬åŠçã«å容ã§ããé žä»
å å¡©ã«ã¯ç¡æ¯æ§ã®é žä»å å¡©ã圢æããåŒ·é žãã
ãšãã°å¡©é žãèåæ°ŽçŽ é žãç¡«é žãç¡é žãã·ãŠãŠ
é žããã³ã¡ã¿ã³ã¹ã«ãã³é žãã圢æããããã®
ãå«ãŸããã ãããã®å¡©ã¯åžžæ³ã«ãããããšãã°åœã¢ã«éã®
éé¢å¡©åºããã³åžæããé žãå«æãã溶液ãæ··å
ããå¿ èŠãªå¡©ãäžæº¶æ§ã§ããå Žåã«ã¯ãããé
ã«ããæ¡åãããŸãã¯æº¶å€ã®èžçºã«ããæ¡åã
ãã åŒïŒïŒã®ååç©ããã³ãããã®è¬åŠçã«å容
ã§ããå¡©ã¯ããããå«ãåç©ã«ãããŠçèææã«
察åŠããã®ã«æçšãªæçèè¬ã§ãããããšãã°ã
ããã¯ããã«ãããŠãšãããã«ã³ãžãå±
ïŒCandidaïŒãããªã³ãã€ãã³å±ïŒTricophytonïŒã
ãã¯ãã¹ãã«ã å±ïŒMicrosporumïŒãããã¯ãš
ããã«ã¢ãã€ãã³å±ïŒEpidermophytonïŒã®èçš®
ã«ãã€ãŠèµ·ããå±æçãªçèææã®æ²»çããŸãã¯
ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ïŒCandida albicansïŒ
ã«ãã€ãŠèµ·ããç²èææïŒããšãã°å£è ã«ã³ãžã
çããã³è ã«ã³ãžãçïŒã«æçšã§ããããããã¯
ãŸãããšãã°ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã»ã¯ãªãã
ã³ãã¯ã¹ã»ããªãã«ãã³ã¹ïŒCryptococcus
neoformansïŒãã¢ã¹ãã«ã®ã«ã¹ã»ããã¬ãŒã¿ã¹
ïŒAsperqillvs fumigatusïŒãã³ã¯ã·ãžãªã€ãã¹
ïŒCoccidioidesïŒããã©ã³ã¯ãžãžãªã€ãã¹å±
ïŒParacoccidioidesïŒããã¹ããã©ã¹ãå±
ïŒHistoplasmaïŒãŸãã¯ãã©ã¹ããã»ã¹å±
ïŒBlastomycesïŒã®èã«ãã€ãŠèµ·ããå šèº«æ§çè
ææã®æ²»çã«éããŠå šèº«çã«çšããããšãã§ã
ãã ååç©ã®æçè掻æ§ã®ã€ã³ãããè©äŸ¡ã¯ãé©å
ãªå¹å°ã«ãããŠç¹å®ã®åŸ®çç©ãçºè²ã§ããªããªã
被éšååç©ã®æå°çºè²é»æ¢æ¿åºŠïŒm.i.c.ïŒãå€å®
ããããšã«ãã€ãŠè¡ãããšãã§ãããå®éã«ã¯ã
ããããç¹å®æ¿åºŠã®è¢«éšååç©ãå«æããäžé£ã®
å¯å€©å¹³æ¿ã«ããšãã°ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã®æš
æºå¹é€ç©ãæ¥çš®ãã次ãã§åå¹³æ¿ã37âã§48æé
ã€ã³ããŠããŒãããã次ãã§çèçºè²ã®æç¡ã«ã€
ãå¹³æ¿ãæ€æ»ããé©å®ãªæå°çºè²é»æ¢æ¿åºŠãèšé²
ããããã®çš®ã®è©Šéšã«çšããããä»ã®åŸ®çç©ã«ã¯
ã¯ãªããã³ãã¯ã¹ã»ããªãã«ãã³ã¹ãã¢ã¹ãã«ã®
ã«ã¹ã»ããã¬ãŒã¿ã¹ãããªã³ãã€ãã³å±èããã¯
ãã¹ãã«ã å±èããšããã«ã¢ãã€ãã³ã»ãããã³
ãµã ïŒEpidermophyton floccosumïŒãã³ã¯ã·ãž
ãªã€ãã¹ã»ã€ããã¹ïŒC.immitisïŒããã³ãã«ã
ãã·ã¹ã»ã°ã©ãã©ãŒã¿ïŒTorulopsis glabrataïŒ
ãå«ãŸããã ååç©ã®ã€ã³ããè©äŸ¡ã¯ãã«ã³ãžãã»ã¢ã«ãã«
ã³ã¹ã®èæ ªãæ¥çš®ãããããŠã¹ã«äžé£ã®çšéæ°Žæº
ã§è ¹è å ãŸãã¯éèå ã«æ³šå°ããããšã«ãã€ãŠè¡
ãããšãã§ããã掻æ§ã¯48æéã®èŠ³å¯åŸã«æªåŠç
ã°ã«ãŒãã®ããŠã¹ãæ»äº¡ããã®ã¡ã®åŠçã°ã«ãŒã
ã®ããŠã¹ã®çåæ°ã«åºã¥ããã®ã§ãããååç©ã
ææã®èŽæ»äœçšã«å¯ŸããŠ50ïŒ ã®é²åŸ¡ã瀺ããçšé
æ°Žæºãèšé²ããã ããã«çšããããã«ã¯åŒïŒïŒã®æçèæ§åå
ç©ãåç¬ã§æäžããããšãã§ããããäžè¬ã«ã¯æ
å³ããæäžçµè·¯ããã³æšæºçãªè¬åŠçå®å°ã«é¢é£
ããŠéžã°ããè¬å€ãã€ãªã€ãŒãšã®æ··åç©ãšããŠæ
äžãããã§ããããããšãã°ãããã¯ãã³ãã³ã
ããã¯ä¹³ç³ãªã©ã®è³Šåœ¢å€ãå«æããé å€ã®åœ¢ã§ã
ãŸãã¯ã«ãã»ã«ãããã¯åµåœ¢å€äžã§åç¬ã§ããã
ã¯è³Šåœ¢å€ãšã®æ··åç©ãšããŠããŸãã¯ç¯å³å€ããã
ã¯çè²å€ãå«æãããšãªãã·ã«å€ãããã¯æžæ¿å€
ã®åœ¢ã§çµå£æäžããããšãã§ãããããããéçµ
å£çã«ãããšãã°éèå ãçèå ãŸãã¯ç®äžã«æ³š
å°ããããšãã§ãããéçµå£æäžã®ããã«ã¯ãä»
ã®ç©è³ªïŒããšãã°æº¶æ¶²ãç匵ã«ããã®ã«ååãª
å¡©ïŒãå«æããŠããŠãããæ» è氎溶液ã®åœ¢ã§ãã
ããçšããããšãæè¯ã§ããã æ£è ã«çµå£ãŸãã¯éçµå£æäžããããã«ã¯ãåŒ
ïŒïŒã®æçèæ§ååç©ã®ïŒæ¥éã¯çµå£çãŸãã¯
éçµå£ççµè·¯ã«ããæäžããé0.1ã10mgïŒKg
ïŒåå²æäžïŒã§ããããšäºæ³ããããããšãã°æ¬
ååç©ã®é å€ãŸãã¯ã«ãã»ã«å€ã¯ãé©æïŒåãªã
ããã以äžã®æäžã®ããïŒmgã0.5ïœã®æŽ»æ§åå
ç©ãå«æãããšäºæ³ããããšãã§ãããå»åž«ã¯ã
ããã«ããæ£è å人ã«æé©ãšæãããå®éã®çšé
ãå€å®ããã§ããããããã¯ãã®æ£è ã®å¹Žä»€ãäœ
éããã³åå¿ã«å¿ããŠå€åããã§ããããåèšã®
çšéã¯å¹³åççäŸã®äžäŸã§ããããã¡ããããã
ããé«ãããŸãã¯äœãçšéç¯å²ãæå©ã§ããåã
ã®äŸãããããããããã¯æ¬çºæã®ç¯å²ã«å å«ã
ããã ãããã¯åŒïŒïŒã®æçèæ§ååç©ãåå€ãŸã
ã¯ãããµãªãŒã®åœ¢ã§æçšããããããŒã·ãšã³ã溶
液ãã¯ãªãŒã ãè»ãããŸãã¯æ£ç²å€ã®åœ¢ã§å±ææ
äžããããšãã§ãããããšãã°ãããã¯ããªãšã
ã¬ã³ã°ãªã³ãŒã«ãŸãã¯æµåãã©ãã€ã³ã®æ°Žæ§ãšã
ã«ãžãšã³ãããªãã¯ãªãŒã ã«å«æããããããã
ãã¯å¿ èŠãªå®å®å€ããã³ä¿åå€ãšå ±ã«çœãããŸã
ã¯çœè²è»ããåºå€ãããªãè»ããã«ïŒã10ïŒ ã®æ¿
床ã§å«æãããããšãã§ããã æ¬ååç©ã¯ãçèææãæ ¹çµ¶ãããŸãã¯äºé²ã
ãããã«æ€ç©ããã³çš®åãåŠçãã蟲æ¥çšã®æ®ºç
èè¬ãšããŠãæçšã§ããã 以äžã®å®æœäŸã¯æ¬çºæãå ·äœçã«èª¬æãããã®
ã§ããã å®æœäŸ ïŒ ïŒâãïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâ
ããããã·âïŒâïŒïŒïŒïŒïŒïŒâããªã¢ãŸãŒã«
âïŒâã€ã«ããªïŒâãããã«ãâïŒïŒïŒïŒïŒâã
ãªã¢ãŸãŒã« ïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâïŒ1Hâ
ïŒïŒïŒïŒïŒâããªã¢ãŸãŒã«âïŒâã€ã«ã¡ãã«ïŒâ
ãªãã·ã©ã³ã»ã¡ã¿ã³ã¹ã«ãã³é žå¡©ïŒïœïŒ0.0137ã¢
ã«ïŒãïŒâã¡ã«ã«ããâïŒïŒïŒïŒïŒâããªã¢ãŸãŒ
ã«ïŒïœïŒ0.05ã¢ã«ïŒããã³ç¡æ°Žçé žã«ãªãŠã 14ïœ
ïŒ0.1ã¢ã«ïŒã也ç¥ãžã¡ãã«ãã«ã ã¢ãã100mläž
ã§80âã«ãããŠïŒæéæªæããã次ãã§æº¶å€ãèž
çºãããæ®æ»ãæ°Žã«æº¶è§£ããå¡©åã¡ãã¬ã³ã§æœåº
ãããæœåºæ¶²ã«åãããŠåžçé žæ°ŽçŽ ãããªãŠã 溶
液ã§ïŒåæŽæµãã也ç¥ããïŒMgSO4ïŒãèžçºãã
ãŠãåºäœæ®æ»ãåŸãããããã€ãœãããããŒã«ïŒ
æ°Žããåçµæ¶ããŠè¡šé¡ã®ååç©3.7ïœïŒ74ïŒ ïŒã
åŸããèç¹180ã182âã å çŽ åæïŒïŒ ïŒïŒ å®æž¬å€ïŒïŒ£ïŒ42.29ïŒïŒšïŒ3.30ïŒïŒ®ïŒ22.86 çè«å€ïŒC13H12N6OSCl2 ïŒ42.07ïŒïŒšïŒ3.26ïŒïŒ®ïŒ22.64 å®æœäŸ ïŒ ïŒâãïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâ
ããããã·âïŒâïŒïŒâã¡ãã«ã€ãããŸãŒã«â
ïŒâã€ã«ããªïŒâãããã«ãâïŒïŒïŒïŒïŒâããª
ã¢ãŸãŒã« ïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâïŒ1Hâ
ïŒïŒïŒïŒïŒâããªã¢ãŸãŒã«âïŒâã€ã«ã¡ãã«ïŒâ
ãªãã·ã©ã³0.27ïœïŒ0.001ã¢ã«ïŒããã³ïŒâã¡ã«
ã«ããâïŒâã¡ãã«ã€ãããŸãŒã«0.228ïœïŒ0.002
ã¢ã«ïŒããžãªããµã³äžã§éæµäžã«72æéå ç±ã
ãã次ãã§ãžãªããµã³ãèžçºãããæ®æ»ãé ¢é žãš
ãã«70mlã«æº¶è§£ããã溶液ãåžçé žã«ãªãŠã 溶
液ãåžæ°Žé žåãããªãŠã 溶液ã§é 次æŽæµãã也ç¥
ããïŒMgSO4ïŒãèžçºãããŠãæ²¹ãåŸããããã¯
æŸçœ®ãããšçµæ¶åãããé ¢é žãšãã«ïŒãããµã³ã
ãåçµæ¶ããŠãè¡šé¡ã®ååç©0.252ïœïŒ66ïŒ ïŒã
åŸããèç¹159ã161âã å çŽ åæïŒïŒ ïŒïŒ å®æž¬å€ïŒïŒ£ïŒ46.97ïŒïŒšïŒ3.84ïŒïŒ®ïŒ18.62 çè«å€ïŒC15H15N5OSCl2 ïŒ46.88ïŒïŒšïŒ3.93ïŒïŒ®ïŒ18.23 å®æœäŸ ïŒ ïŒâãïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâ
ããããã·âïŒâïŒãã¢ãŸãŒã«âïŒâã€ã«ããªïŒ
âãããã«ãâïŒïŒïŒïŒïŒâããªã¢ãŸãŒã« ïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâïŒ1Hâ
ïŒïŒïŒïŒïŒâããªã¢ãŸãŒã«âïŒâã€ã«ã¡ãã«ïŒâ
ãªãã·ã©ã³ã»ã¡ã¿ã³ã¹ã«ãã³é žå¡©ïŒïœïŒ0.0164ã¢
ã«ïŒããã³ïŒâã¡ã«ã«ãããã¢ãŸãŒã«ïŒïœïŒ0.05
ã¢ã«ïŒãæ°·é ¢é ž200mläžã§éæµäžã«ïŒæéå ç±ã
ãã次ãã§æº¶å€ãèžçºãããæ®æ»ãåžæ°Žé žåãã
ãªãŠã 溶液ã§å¡©åºæ§ãšãªããå¡©åã¡ãã¬ã³ã§æœåº
ãããæœåºæ¶²ãåžæ°Žé žåãããªãŠã 溶液ã§ïŒåæŽ
æµãã也ç¥ããïŒïŒïœSO4ïŒãèžçºãããŠãæ·¡è€
è²ã¬ã©ã¹æ§ç©è³ª5.4ïœãåŸãããããã·ãªã«äžã§
é ¢é žãšãã«ïŒãšãŒãã«ïŒã¡ã¿ããŒã«ïŒãžãšãã«ã¢
ãã³25ïŒ75ïŒïŒïŒïŒã«ãã溶é¢ãããŠã¯ãããã°
ã©ãã€ãŒåŠçããã€ãœãããããŒã«ããïŒååçµ
æ¶ããã®ã¡ãè¡šé¡ã®ååç©ïŒïœïŒ32ïŒ ïŒãåŸãã
èç¹110ã111âã å çŽ åæïŒïŒ ïŒïŒ å®æž¬å€ïŒïŒ£ïŒ43.36ïŒïŒšïŒ3.12ïŒïŒ®ïŒ14.83 çè«å€ïŒC14H11N4OS2Cl2 ïŒ43.43ïŒïŒšïŒ3.12ïŒïŒ®ïŒ14.47 å®æœäŸ ïŒã19 å®æœäŸïŒãïŒã«èšèŒããäžè¬çæ¹æ³ã«ãããã
ã ãé©å®ãªè€çŽ ç°åŒããªãŒã«ãçšããŠãäžèšã®å
åç©ã補é ããã
ãè¡šã
ãè¡šã
ãè¡šã
å®æœäŸ 21
ïŒâãïŒâïŒïŒâã¢ã»ãã¢ããâïŒïŒïŒïŒïŒâã
ã¢ãžã¢ãŸãŒã«âïŒâã€ã«ããªïŒâïŒâïŒïŒïŒïŒâ
ãžã¯ãã«ããšãã«ïŒâïŒâããããã·âããã
ã«ãâïŒïŒïŒïŒïŒâããªã¢ãŸãŒã« ïŒâãïŒâïŒïŒâã¢ããâïŒïŒïŒïŒïŒâãã¢ãžã¢
ãŸãŒã«âïŒâã€ã«ããªïŒâïŒâïŒïŒïŒïŒâãžã¯ãã«
ããšãã«ïŒâïŒâããããã·âãããã«ãâïŒïŒ
ïŒïŒïŒâããªã¢ãŸãŒã«0.5ïœïŒ0.00124ïœïŒã宀枩
ã§ç¡æ°Žé ¢é ž0.5mlããã³ããªãžã³ïŒmlã®æ··åç©ãš
å ±ã«ïŒæéæªæãããåŸãããåºäœãåããæ°Ž
æŽãã也ç¥ãããŠãè¡šé¡ã®ååç©0.44ïœïŒ80ïŒ ïŒ
ãåŸããèç¹132âã å çŽ åæïŒïŒ ïŒïŒ å®æž¬å€ïŒïŒ£ïŒ39.78ïŒïŒšïŒ3.39ïŒïŒ®ïŒ18.82 çè«å€ïŒC15H14N6OS2Cl2 ïŒ39.65ïŒïŒšïŒ3.32ïŒïŒ®ïŒ18.49 å®æœäŸ 22 ïŒâãïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâ
ããããã·âïŒâïŒïŒâã¡ãã«âã€ãããŸãŒã«
âïŒâã€ã«ã¹ã«ãã€ãã«ïŒâãããã«ãâïŒïŒ
ïŒïŒïŒâããªã¢ãŸãŒã« ïŒâãïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâ
ããããã·âïŒâïŒïŒâã¡ãã«âã€ãããŸãŒã«â
ïŒâã€ã«ããªïŒâãããã«ãâïŒïŒïŒïŒïŒâããªã¢
ãŸãŒã«250mgïŒ0.65mMïŒãå¡©åã¡ãã¬ã³ïŒmlã
ãã³ã€ãœãããããŒã«ïŒmlã®æ··åç©ã«æº¶è§£ããã
溶液ãæªæããæ°·äžã§å·åŽããããã®æº¶æ¶²ã10å
éã«ããã€ãŠïŒåã«åããŠã¡ã¿ã¯ãã«éå®æ¯éŠé ž
ïŒçŽåºŠ85ïŒ ïŒ132mgïŒ0.65mMïŒã«æ·»å ããã宀枩
ã§18æéåå¿ãè¡ããããå¡©åã¡ãã¬ã³100mlã
æ·»å ããææ©å±€ãåé¢ããæ°Ž100mläžã®çé žãã
ãªãŠã 2.5ïœããã³ã¡ã¿éäºç¡«é žãããªãŠã 2.5ïœ
ã®æº¶æ¶²ã§æŽæµããã次ãã§ææ©å±€ãç¡«é žãã°ãã·
ãŠã äžã§ä¹Ÿç¥ãããèžçºãããŠãçæç©ãïŒçš®ã®
ã¹ã«ããã·ããžã¢ã¹ãã¬ãªããŒã®æ··åç©ãšããŠåŸ
ãããããã®ååç©ãã·ãªã«äžã§é ¢é žãšãã«ãã¡
ã¿ããŒã«ããã³æ¿æ°Žé žåã¢ã³ã¢ããŠã ïŒ80ïŒ20ïŒ
ïŒïŒã®æ··åç©ã§æº¶é¢ããŠã¯ãããã°ã©ãã€ãŒåŠç
ããRf0.40ïŒã·ãªã«ãé ¢é žãšãã«ïŒã¡ã¿ããŒã«ïŒ
æ°Žé žåã¢ã³ã¢ããŠã 80ïŒ20ïŒïŒïŒã®äž»çæç©ãåŸ
ãããããé ¢é žãšãã«ïŒãããµã³ããåçµæ¶ã
ãŠãè¡šé¡ã®ååç©ãç°æ§äœïŒïŒ140mgã54ïŒ ïŒãšã
ãŠåŸããèç¹175ã178âïŒå解ïŒã å çŽ åæïŒïŒ ïŒïŒ å®æž¬å€ïŒïŒ£ïŒ44.89ïŒïŒšïŒ3.87ïŒïŒ®ïŒ17.80 çè«å€ïŒC15H15N5O2SCl2 ïŒ45.01ïŒïŒšïŒ3.87ïŒïŒ®ïŒ17.50 ããã«æº¶é¢ããŠRf0.27ïŒåäžç³»ïŒã®å¯æåãåŸ
ãããããé ¢é žãšãã«ïŒãããµã³ããåçµæ¶ããŠ
è¡šé¡ã®ååç©ãç°æ§äœïŒïŒ60mgã23ïŒ ïŒãšããŠåŸ
ããèç¹162ã164âã å çŽ åæïŒïŒ ïŒïŒ å®æž¬å€ïŒïŒ£ïŒ45.11ïŒïŒšïŒ3.69ïŒïŒ®ïŒ17.19 çè«å€ïŒC15H15N5O2SCl2 ïŒ45.01ïŒïŒšïŒ3.78ïŒïŒ®ïŒ17.50 å®æœäŸ 23 ïŒâãïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâ
ããããã·âïŒâïŒïŒïŒïŒâãžã¡ãã«ãã¢ãŸãŒ
ã«âïŒâã€ã«âã¹ã«ãã€ãã«ïŒâãããã«ãâ
ïŒïŒïŒïŒïŒâããªã¢ãŸãŒã« å®æœäŸ22ã®æäœã«åŸãããã ãïŒâãïŒâïŒïŒïŒ
ïŒâãžã¯ãã«ããšãã«ïŒâïŒâããããã·âïŒâ
ïŒïŒïŒïŒâãžã¡ãã«ãã¢ãŸãŒã«âïŒâã€ã«ããªïŒâ
ãããã«ãâïŒïŒïŒïŒïŒâããªã¢ãŸãŒã«250mgãã
åºçºããŠãè¡šé¡ã®ã¹ã«ããã·ãïŒç°æ§äœïŒïŒ20mg
ïŒïŒïŒ ïŒãåŸããèç¹199ã200âã å çŽ åæïŒïŒ ïŒïŒ å®æž¬å€ïŒïŒ£ïŒ44.47ïŒïŒšïŒ3.67ïŒïŒ®ïŒ13.02 çè«å€ïŒC16H16N4OS2Cl2 ïŒ44.55ïŒïŒšïŒ3.71ïŒïŒ®ïŒ12.99 åèäŸ ä»¥äžã«çèææã®æ²»çã«çšããããè¬å€çµæç©
ã«ã€ãå ·äœçã«ç€ºãã (1) ã«ãã»ã«å€ïŒå®æœäŸïŒã®ååç©71éééšããš
ãããããã§ãã·ãïŒéšããã³ä¹³ç³22éšãšå ±ã«
é¡ç²åããã®ã¡ããšãããããã§ãã·ãïŒéšã
ãã³ã¹ãã¢ãªã³é žãã°ãã·ãŠã ïŒéšãè¿œå ã
ããæ··åç©ãå床é¡ç²åãã硬質ãŒã©ãã³ã«ã
ã»ã«ã«å å¡«ããã (2) ã¯ãªãŒã ïŒå®æœäŸïŒã®ååç©ããããã¬ã³ã°
ãªã³ãŒã«10éšã«æº¶è§£ããããã·ã³ã°ã¯ãªãŒã åº
å€88éšã«æ··å ¥ããã (3) ãããµãªãŒïŒå®æœäŸïŒã®ååç©ïŒéééšãå
æž©ãã液ååå€åºå€98éšã«æžæ¿ãããããåã«
æ³šå ¥ããŠåºåãããã 補é äŸ ïŒ ïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâïŒ1Hâ
ïŒïŒïŒïŒïŒâããªã¢ãŸãŒã«âïŒâã€ã«ã¡ãã«ïŒ
âãªãã·ã©ã³ã®è£œé æ°ŽçŽ åãããªãŠã 3.78ïœïŒ0.079ã¢ã«ãæ²¹äžã®
50ïŒ æžæ¿æ¶²ãšããŠïŒãæªæäžã«ä¹Ÿç¥ãžãšãã«ãšãŒ
ãã«20mlã«æžæ¿ããã次ãã§ãšãŒãã«ããã«ã³ã
ãŒã·ãšã³ã«ããé€å»ããæ°ŽçŽ åãããªãŠã ã也ç¥
çªçŽ æ°æµäžã§ä¹Ÿç¥ãããã也ç¥ãžã¡ãã«ã¹ã«ãã
ã·ã100mlãæ·»å ããã®ã¡ã也ç¥ç²æ«ç¶ã®ãšãŠå
ããªã¡ãã«ã¹ã«ãããœããŠã 17.34ïœïŒ0.079ã¢
ã«ïŒã15åéã«ããã€ãŠå°éãã€æ·»å ãããåŸã
ããæ··åç©ã宀枩ïŒ20âïŒã§30åéæªæããã次
ãã§ïŒâïŒ1HâïŒïŒïŒïŒïŒâããªã¢ãŸãŒã«âïŒâ
ã€ã«ïŒâ2â²ïŒïŒâãžã¯ãã«ã¢ã»ãããšãã³18.33ïœ
ïŒ0.072ã¢ã«ïŒã也ç¥ãžã¡ãã«ã¹ã«ããã·ã50mläž
ã®æº¶æ¶²ãšããŠæ·»å ãããæ··åç©ã60âã§ïŒæéå
ç±ãã宀枩ã§äžå€æŸçœ®ãããåå¿æ··åç©ãå·åŽ
ããæ°·äžã§æ¥å·ããã次ãã§çæç©ãé ¢é žãšãã«
600mläžã«æœåºãããé ¢é žãšãã«å±€ãåé¢ããç¡«
é žãã°ãã·ãŠã äžã§ä¹Ÿç¥ãããæ¿çž®ããŠãèµ€è²ãŽ
ã ç¶ç©ãåŸãããã®ãŽã ç¶ç©ãã·ãªã«äžã§ãšãŒã
ã«ã«ãã溶解ããŠã«ã©ã ã¯ãããã°ã©ãã€ãŒåŠç
ããè¡šé¡ã®ååç©6.62ïœïŒ34.4ïŒ ïŒããŽã ç¶ç©ãš
ããŠåŸãã
ã¢ãžã¢ãŸãŒã«âïŒâã€ã«ããªïŒâïŒâïŒïŒïŒïŒâ
ãžã¯ãã«ããšãã«ïŒâïŒâããããã·âããã
ã«ãâïŒïŒïŒïŒïŒâããªã¢ãŸãŒã« ïŒâãïŒâïŒïŒâã¢ããâïŒïŒïŒïŒïŒâãã¢ãžã¢
ãŸãŒã«âïŒâã€ã«ããªïŒâïŒâïŒïŒïŒïŒâãžã¯ãã«
ããšãã«ïŒâïŒâããããã·âãããã«ãâïŒïŒ
ïŒïŒïŒâããªã¢ãŸãŒã«0.5ïœïŒ0.00124ïœïŒã宀枩
ã§ç¡æ°Žé ¢é ž0.5mlããã³ããªãžã³ïŒmlã®æ··åç©ãš
å ±ã«ïŒæéæªæãããåŸãããåºäœãåããæ°Ž
æŽãã也ç¥ãããŠãè¡šé¡ã®ååç©0.44ïœïŒ80ïŒ ïŒ
ãåŸããèç¹132âã å çŽ åæïŒïŒ ïŒïŒ å®æž¬å€ïŒïŒ£ïŒ39.78ïŒïŒšïŒ3.39ïŒïŒ®ïŒ18.82 çè«å€ïŒC15H14N6OS2Cl2 ïŒ39.65ïŒïŒšïŒ3.32ïŒïŒ®ïŒ18.49 å®æœäŸ 22 ïŒâãïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâ
ããããã·âïŒâïŒïŒâã¡ãã«âã€ãããŸãŒã«
âïŒâã€ã«ã¹ã«ãã€ãã«ïŒâãããã«ãâïŒïŒ
ïŒïŒïŒâããªã¢ãŸãŒã« ïŒâãïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâ
ããããã·âïŒâïŒïŒâã¡ãã«âã€ãããŸãŒã«â
ïŒâã€ã«ããªïŒâãããã«ãâïŒïŒïŒïŒïŒâããªã¢
ãŸãŒã«250mgïŒ0.65mMïŒãå¡©åã¡ãã¬ã³ïŒmlã
ãã³ã€ãœãããããŒã«ïŒmlã®æ··åç©ã«æº¶è§£ããã
溶液ãæªæããæ°·äžã§å·åŽããããã®æº¶æ¶²ã10å
éã«ããã€ãŠïŒåã«åããŠã¡ã¿ã¯ãã«éå®æ¯éŠé ž
ïŒçŽåºŠ85ïŒ ïŒ132mgïŒ0.65mMïŒã«æ·»å ããã宀枩
ã§18æéåå¿ãè¡ããããå¡©åã¡ãã¬ã³100mlã
æ·»å ããææ©å±€ãåé¢ããæ°Ž100mläžã®çé žãã
ãªãŠã 2.5ïœããã³ã¡ã¿éäºç¡«é žãããªãŠã 2.5ïœ
ã®æº¶æ¶²ã§æŽæµããã次ãã§ææ©å±€ãç¡«é žãã°ãã·
ãŠã äžã§ä¹Ÿç¥ãããèžçºãããŠãçæç©ãïŒçš®ã®
ã¹ã«ããã·ããžã¢ã¹ãã¬ãªããŒã®æ··åç©ãšããŠåŸ
ãããããã®ååç©ãã·ãªã«äžã§é ¢é žãšãã«ãã¡
ã¿ããŒã«ããã³æ¿æ°Žé žåã¢ã³ã¢ããŠã ïŒ80ïŒ20ïŒ
ïŒïŒã®æ··åç©ã§æº¶é¢ããŠã¯ãããã°ã©ãã€ãŒåŠç
ããRf0.40ïŒã·ãªã«ãé ¢é žãšãã«ïŒã¡ã¿ããŒã«ïŒ
æ°Žé žåã¢ã³ã¢ããŠã 80ïŒ20ïŒïŒïŒã®äž»çæç©ãåŸ
ãããããé ¢é žãšãã«ïŒãããµã³ããåçµæ¶ã
ãŠãè¡šé¡ã®ååç©ãç°æ§äœïŒïŒ140mgã54ïŒ ïŒãšã
ãŠåŸããèç¹175ã178âïŒå解ïŒã å çŽ åæïŒïŒ ïŒïŒ å®æž¬å€ïŒïŒ£ïŒ44.89ïŒïŒšïŒ3.87ïŒïŒ®ïŒ17.80 çè«å€ïŒC15H15N5O2SCl2 ïŒ45.01ïŒïŒšïŒ3.87ïŒïŒ®ïŒ17.50 ããã«æº¶é¢ããŠRf0.27ïŒåäžç³»ïŒã®å¯æåãåŸ
ãããããé ¢é žãšãã«ïŒãããµã³ããåçµæ¶ããŠ
è¡šé¡ã®ååç©ãç°æ§äœïŒïŒ60mgã23ïŒ ïŒãšããŠåŸ
ããèç¹162ã164âã å çŽ åæïŒïŒ ïŒïŒ å®æž¬å€ïŒïŒ£ïŒ45.11ïŒïŒšïŒ3.69ïŒïŒ®ïŒ17.19 çè«å€ïŒC15H15N5O2SCl2 ïŒ45.01ïŒïŒšïŒ3.78ïŒïŒ®ïŒ17.50 å®æœäŸ 23 ïŒâãïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâ
ããããã·âïŒâïŒïŒïŒïŒâãžã¡ãã«ãã¢ãŸãŒ
ã«âïŒâã€ã«âã¹ã«ãã€ãã«ïŒâãããã«ãâ
ïŒïŒïŒïŒïŒâããªã¢ãŸãŒã« å®æœäŸ22ã®æäœã«åŸãããã ãïŒâãïŒâïŒïŒïŒ
ïŒâãžã¯ãã«ããšãã«ïŒâïŒâããããã·âïŒâ
ïŒïŒïŒïŒâãžã¡ãã«ãã¢ãŸãŒã«âïŒâã€ã«ããªïŒâ
ãããã«ãâïŒïŒïŒïŒïŒâããªã¢ãŸãŒã«250mgãã
åºçºããŠãè¡šé¡ã®ã¹ã«ããã·ãïŒç°æ§äœïŒïŒ20mg
ïŒïŒïŒ ïŒãåŸããèç¹199ã200âã å çŽ åæïŒïŒ ïŒïŒ å®æž¬å€ïŒïŒ£ïŒ44.47ïŒïŒšïŒ3.67ïŒïŒ®ïŒ13.02 çè«å€ïŒC16H16N4OS2Cl2 ïŒ44.55ïŒïŒšïŒ3.71ïŒïŒ®ïŒ12.99 åèäŸ ä»¥äžã«çèææã®æ²»çã«çšããããè¬å€çµæç©
ã«ã€ãå ·äœçã«ç€ºãã (1) ã«ãã»ã«å€ïŒå®æœäŸïŒã®ååç©71éééšããš
ãããããã§ãã·ãïŒéšããã³ä¹³ç³22éšãšå ±ã«
é¡ç²åããã®ã¡ããšãããããã§ãã·ãïŒéšã
ãã³ã¹ãã¢ãªã³é žãã°ãã·ãŠã ïŒéšãè¿œå ã
ããæ··åç©ãå床é¡ç²åãã硬質ãŒã©ãã³ã«ã
ã»ã«ã«å å¡«ããã (2) ã¯ãªãŒã ïŒå®æœäŸïŒã®ååç©ããããã¬ã³ã°
ãªã³ãŒã«10éšã«æº¶è§£ããããã·ã³ã°ã¯ãªãŒã åº
å€88éšã«æ··å ¥ããã (3) ãããµãªãŒïŒå®æœäŸïŒã®ååç©ïŒéééšãå
æž©ãã液ååå€åºå€98éšã«æžæ¿ãããããåã«
æ³šå ¥ããŠåºåãããã 補é äŸ ïŒ ïŒâïŒïŒïŒïŒâãžã¯ãã«ããšãã«ïŒâïŒâïŒ1Hâ
ïŒïŒïŒïŒïŒâããªã¢ãŸãŒã«âïŒâã€ã«ã¡ãã«ïŒ
âãªãã·ã©ã³ã®è£œé æ°ŽçŽ åãããªãŠã 3.78ïœïŒ0.079ã¢ã«ãæ²¹äžã®
50ïŒ æžæ¿æ¶²ãšããŠïŒãæªæäžã«ä¹Ÿç¥ãžãšãã«ãšãŒ
ãã«20mlã«æžæ¿ããã次ãã§ãšãŒãã«ããã«ã³ã
ãŒã·ãšã³ã«ããé€å»ããæ°ŽçŽ åãããªãŠã ã也ç¥
çªçŽ æ°æµäžã§ä¹Ÿç¥ãããã也ç¥ãžã¡ãã«ã¹ã«ãã
ã·ã100mlãæ·»å ããã®ã¡ã也ç¥ç²æ«ç¶ã®ãšãŠå
ããªã¡ãã«ã¹ã«ãããœããŠã 17.34ïœïŒ0.079ã¢
ã«ïŒã15åéã«ããã€ãŠå°éãã€æ·»å ãããåŸã
ããæ··åç©ã宀枩ïŒ20âïŒã§30åéæªæããã次
ãã§ïŒâïŒ1HâïŒïŒïŒïŒïŒâããªã¢ãŸãŒã«âïŒâ
ã€ã«ïŒâ2â²ïŒïŒâãžã¯ãã«ã¢ã»ãããšãã³18.33ïœ
ïŒ0.072ã¢ã«ïŒã也ç¥ãžã¡ãã«ã¹ã«ããã·ã50mläž
ã®æº¶æ¶²ãšããŠæ·»å ãããæ··åç©ã60âã§ïŒæéå
ç±ãã宀枩ã§äžå€æŸçœ®ãããåå¿æ··åç©ãå·åŽ
ããæ°·äžã§æ¥å·ããã次ãã§çæç©ãé ¢é žãšãã«
600mläžã«æœåºãããé ¢é žãšãã«å±€ãåé¢ããç¡«
é žãã°ãã·ãŠã äžã§ä¹Ÿç¥ãããæ¿çž®ããŠãèµ€è²ãŽ
ã ç¶ç©ãåŸãããã®ãŽã ç¶ç©ãã·ãªã«äžã§ãšãŒã
ã«ã«ãã溶解ããŠã«ã©ã ã¯ãããã°ã©ãã€ãŒåŠç
ããè¡šé¡ã®ååç©6.62ïœïŒ34.4ïŒ ïŒããŽã ç¶ç©ãš
ããŠåŸãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ æ¬¡åŒ ïŒåŒäžArã¯ïŒïŒïŒâãžããããšãã«åºã§ããã ïœã¯ïŒãŸãã¯ïŒã§ããã Hetã¯ïŒâã€ãããŸãªã«åºãïŒâãã¢ãŸãªã«
åºãïŒâïŒïŒïŒïŒïŒïŒâããªã¢ãŸãªã«ïŒåºãïŒâ
ããã©ãŸãªã«åºãïŒâïŒïŒïŒïŒïŒïŒâãã¢ãžã¢ãŸ
ãªã«åºïŒãïŒâãïŒâãããã¯ïŒâããªãžã«åºã
ïŒâãããã¯ïŒâããªããžãã«åºããããªã«åºãŸ
ãã¯ããªãã«åºã§ãããããããè€çŽ ç°ãŸãã¯çž®
åããšãã«ç°ã«ãããŠïŒåãŸãã¯ãã以äžã®ãã
ã²ã³ãCF3ãC1âC4ã¢ã«ãã«åºãã¢ããåºãã¢ã«
ã«ãã€ã«ã¢ããåºãŸãã¯ããªåºã«ãã眮æãããŠ
ããŠãããïŒã®ååç©ããã³è¬åŠçã«å容ããã
ãããã®å¡©ã ïŒ åŒã§ArãïŒïŒïŒâãžã¯ãã«ããšãã«åºã§
ãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ HetãïŒâã€ãããŸãªã«åºãïŒâïŒïŒâã¡ã
ã«âã€ãããŸãªã«ïŒåºãïŒâãã¢ãŸãªã«åºããŸã
ã¯ïŒâãããã¯ïŒâããªããžãã«åºã§ãããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ æ¬¡åŒ ïŒåŒäžArã¯ïŒïŒïŒâãžããããšãã«åºã§ããã ïœã¯ïŒãŸãã¯ïŒã§ããã Hetã¯ïŒâã€ãããŸãªã«åºãïŒâãã¢ãŸãªã«
åºãïŒâïŒïŒïŒïŒïŒïŒâããªã¢ãŸãªã«ïŒåºãïŒâ
ããã©ãŸãªã«åºãïŒâïŒïŒïŒïŒïŒïŒâãã¢ãžã¢ãŸ
ãªã«åºïŒãïŒâãïŒâãããã¯ïŒâããªãžã«åºã
ïŒâãããã¯ïŒâããªããžãã«åºããããªã«åºãŸ
ãã¯ããªãã«åºã§ãããããããè€çŽ ç°ãŸãã¯çž®
åããšãã«ç°ã«ãããŠïŒåãŸãã¯ãã以äžã®ãã
ã²ã³ãCF3ãC1âC4ã¢ã«ãã«åºãã¢ããåºãã¢ã«
ã«ãã€ã«ã¢ããåºãŸãã¯ããªåºã«ãã眮æãããŠ
ããŠãããïŒã®ååç©ã®è£œæ³ã§ãã€ãŠãæ¬¡åŒ ã®ãªãã·ã©ã³ãæ¬¡åŒ HetâSH ⊠ã®è€çŽ ç°åŒããªãŒã«ïŒåŒäžArããã³Hetã¯åèš
å®çŸ©éãã§ããïŒãšåå¿ãããåŒã«ãããŠïœã
ãŒãã§ããååç©ã圢æããããã«ãå¿ èŠã«å¿ã
ãŠè©²ååç©ãé žåããŠãåŒã«ãããŠïœãïŒã§ã
ãååç©ãçæããå Žåã«ãããããã®å¡©ã圢æ
ãããããšãç¹åŸŽãšããæ¹æ³ã
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8210312 | 1982-04-07 | ||
| GB8210312 | 1982-04-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58189173A JPS58189173A (ja) | 1983-11-04 |
| JPS6320432B2 true JPS6320432B2 (ja) | 1988-04-27 |
Family
ID=10529582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58061497A Granted JPS58189173A (ja) | 1982-04-07 | 1983-04-07 | ããªã¢ãŸãŒã«ç³»æçèååç© |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4678789A (ja) |
| EP (1) | EP0091309B1 (ja) |
| JP (1) | JPS58189173A (ja) |
| DE (1) | DE3374197D1 (ja) |
| DK (1) | DK157135C (ja) |
| GR (1) | GR78172B (ja) |
| IE (1) | IE54972B1 (ja) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8322983D0 (en) * | 1983-08-26 | 1983-09-28 | Pfizer Ltd | Triazole antifungal agents |
| DE3334409A1 (de) * | 1983-09-23 | 1985-04-18 | Bayer Ag, 5090 Leverkusen | Triazolylmethyl-pyridyloxymethyl-carbinol-derivate |
| US4876257A (en) * | 1988-03-03 | 1989-10-24 | Ortho Pharmaceutical Corporation | 6-Substituted purinyl piperazine derivatives useful as cardiotonic and antiarrhythmic agents |
| US5021574A (en) * | 1988-03-03 | 1991-06-04 | Ortho Pharmaceutical Corporation | 6-substituted purinyl piperazine derivatives |
| US5164390A (en) * | 1988-03-03 | 1992-11-17 | Ortho Pharmaceutical Corporation | 6-substituted purinyl piperazine derivatives |
| IE903395A1 (en) * | 1989-09-26 | 1991-04-10 | Takeda Chemical Industries Ltd | Triazole compounds, their production and use |
| TW206224B (ja) * | 1989-12-14 | 1993-05-21 | Takeda Pharm Industry Co Ltd | |
| JPH05262764A (ja) * | 1992-01-24 | 1993-10-12 | Morishita Roussel Kk | ïŒâã¢ãªãŒã«âïŒâïŒïŒïœâïŒïŒïŒïŒïŒâããªã¢ãŸãŒ ã«âïŒâã€ã«ïŒãšã¿ããŒã«èªå°äœ |
| EP0751943A1 (en) * | 1994-03-12 | 1997-01-08 | Yuhan Corporation | Triazole compounds and processes for the preparation thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4654332A (en) * | 1979-03-07 | 1987-03-31 | Imperial Chemical Industries Plc | Heterocyclic compounds |
| DE3000244A1 (de) * | 1980-01-05 | 1981-07-09 | Bayer Ag, 5090 Leverkusen | Triazolylphenacyl-pyridyl-ether-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide |
| DE3018865A1 (de) * | 1980-05-16 | 1981-11-26 | Bayer Ag, 5090 Leverkusen | Antimikrobielle mittel |
| GB2078719B (en) * | 1980-06-02 | 1984-04-26 | Ici Ltd | Heterocyclic compounds |
| DE3177275D1 (de) * | 1980-08-18 | 1992-04-16 | Ici Plc | Verwendung von triazolylaethanol-derivate und deren zusammensetzungen als nichtlandwirtschaftliche fungizide. |
| EP0046633A1 (en) * | 1980-08-22 | 1982-03-03 | Imperial Chemical Industries Plc | Heterocyclic compounds useful as pesticides and processes for making them |
| CA1162540A (en) * | 1980-12-24 | 1984-02-21 | Ikutaro Saji | Imidazolylpropanol compounds and their acid addition salts, and production and use thereof |
| EP0061835B1 (en) * | 1981-03-18 | 1989-02-01 | Imperial Chemical Industries Plc | Triazole compounds, a process for preparing them, their use as plant fungicides and fungicidal compositions containing them |
-
1983
- 1983-02-28 DK DK098383A patent/DK157135C/da not_active IP Right Cessation
- 1983-03-28 US US06/479,525 patent/US4678789A/en not_active Expired - Lifetime
- 1983-04-05 DE DE8383301894T patent/DE3374197D1/de not_active Expired
- 1983-04-05 EP EP83301894A patent/EP0091309B1/en not_active Expired
- 1983-04-06 GR GR71014A patent/GR78172B/el unknown
- 1983-04-06 IE IE773/83A patent/IE54972B1/en not_active IP Right Cessation
- 1983-04-07 JP JP58061497A patent/JPS58189173A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| US4678789A (en) | 1987-07-07 |
| GR78172B (ja) | 1984-09-26 |
| DK98383D0 (da) | 1983-02-28 |
| EP0091309A2 (en) | 1983-10-12 |
| DK98383A (da) | 1983-10-08 |
| IE830773L (en) | 1983-10-07 |
| DE3374197D1 (en) | 1987-12-03 |
| DK157135B (da) | 1989-11-13 |
| IE54972B1 (en) | 1990-04-11 |
| DK157135C (da) | 1990-04-02 |
| EP0091309B1 (en) | 1987-10-28 |
| EP0091309A3 (en) | 1985-04-03 |
| JPS58189173A (ja) | 1983-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0097469B1 (en) | Triazole antifungal agents | |
| US4661507A (en) | Antifungal S-ethers of 2-aryl-3-mercapto-1-(1H-1,2,4-triazol-1-yl) propan-2-ols and corresponding sulfoxides and sulfones | |
| US4505919A (en) | Antifungal S-arylmethyl- and S-heterocyclylmethyl ethers of 2-aryl-3-mercapto-1-(1H-1,2,4-triazol-1-yl) propan-2-ols | |
| EP0097014B1 (en) | Triazole antifungal agents | |
| EP0091309B1 (en) | Triazole antifungal agents | |
| EP0115400B1 (en) | Triazole antifungal agents | |
| KR870001379B1 (ko) | ížëŠ¬ìì¡ž ì ë첎ì ì ì¡°ë°©ë² | |
| US4483863A (en) | Triazole antifungal agents | |
| KR870001006B1 (ko) | ížëŠ¬ìì¡ž ì ë첎ì ì ì¡°ë°©ë² | |
| EP0126581B1 (en) | Antifungal triazole derivatives | |
| EP0101212B1 (en) | Triazole antifungal agents | |
| EP0113509B1 (en) | 1,3-bis(triazolyl)-2-amino-2-aryl-propane derivatives and pharmaceutical fungicidal compositions containing them | |
| EP0102727B1 (en) | Chloropyridyl antifungal agents | |
| JPH0425953B2 (ja) | ||
| JPS635390B2 (ja) | ||
| HU193279B (en) | Process for preparing antifungal triazole derivatives and pharmaceutical compositions comprising such compounds | |
| JPH02152972A (ja) | ïŒâïŒïŒâ眮æâïŒâãã§ãã«ãããã«ïŒâïŒïœâïŒïŒïŒïŒïŒâããªã¢ãŸãŒã«èªå°äœ | |
| CS235337B2 (cs) | Způsob vÜroby derivátů triazolu |